<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Immunotherapy for recurrent miscarriage - Wong, LF - 2014 | Cochrane Library</title> <meta content="Immunotherapy for recurrent miscarriage - Wong, LF - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000112.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Immunotherapy for recurrent miscarriage - Wong, LF - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000112.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD000112.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Immunotherapy for recurrent miscarriage" name="citation_title"/> <meta content="Luchin F Wong" name="citation_author"/> <meta content="T Flint Porter" name="citation_author"/> <meta content="flint.porter@imail.org" name="citation_author_email"/> <meta content="James R Scott" name="citation_author"/> <meta content="University of Utah Medical Centre" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD000112.pub3" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/10/21" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000112.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000112.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000112.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Abortion, Habitual [*prevention &amp; control]; Immunotherapy [*methods]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000112.pub3&amp;doi=10.1002/14651858.CD000112.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000112.pub3&amp;doi=10.1002/14651858.CD000112.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000112.pub3&amp;doi=10.1002/14651858.CD000112.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000112.pub3&amp;doi=10.1002/14651858.CD000112.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000112.pub3&amp;doi=10.1002/14651858.CD000112.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000112.pub3&amp;doi=10.1002/14651858.CD000112.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000112.pub3&amp;doi=10.1002/14651858.CD000112.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000112.pub3&amp;doi=10.1002/14651858.CD000112.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000112.pub3&amp;doi=10.1002/14651858.CD000112.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000112.pub3&amp;doi=10.1002/14651858.CD000112.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000112.pub3&amp;doi=10.1002/14651858.CD000112.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000112.pub3&amp;doi=10.1002/14651858.CD000112.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000112.pub3&amp;doi=10.1002/14651858.CD000112.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000112.pub3&amp;doi=10.1002/14651858.CD000112.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000112.pub3&amp;doi=10.1002/14651858.CD000112.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000112.pub3&amp;doi=10.1002/14651858.CD000112.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000112.pub3&amp;doi=10.1002/14651858.CD000112.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000112.pub3&amp;doi=10.1002/14651858.CD000112.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000112.pub3&amp;doi=10.1002/14651858.CD000112.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000112.pub3&amp;doi=10.1002/14651858.CD000112.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000112.pub3&amp;doi=10.1002/14651858.CD000112.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000112.pub3&amp;doi=10.1002/14651858.CD000112.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000112.pub3&amp;doi=10.1002/14651858.CD000112.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="Xx9QLps0";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD000112\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD000112\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000112\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000112\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD000112.pub3",title:"Immunotherapy for recurrent miscarriage",firstPublishedDate:"Oct 21, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Xx9QLps0&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000112.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000112.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD000112.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD000112.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000112.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD000112.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD000112.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD000112.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD000112.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD000112.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4365 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD000112.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000112.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000112.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000112.pub3/full#CD000112-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000112.pub3/full#CD000112-sec-0102"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000112.pub3/full#CD000112-sec-0022"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000112.pub3/full#CD000112-sec-0027"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000112.pub3/full#CD000112-sec-0028"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000112.pub3/full#CD000112-sec-0064"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000112.pub3/full#CD000112-sec-0096"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000112.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000112.pub3/appendices#CD000112-sec-0107"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000112.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000112.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/table_n/CD000112StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/table_n/CD000112StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000112.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000112.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000112.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000112.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000112.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD000112.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Immunotherapy for recurrent miscarriage</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000112.pub3/information#CD000112-cr-0002">Luchin F Wong</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000112.pub3/information#CD000112-cr-0003"><i class="icon corresponding-author fa fa-envelope"></i>T Flint Porter</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000112.pub3/information#CD000112-cr-0004">James R Scott</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/information/en#CD000112-sec-0117">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 21 October 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD000112.pub3">https://doi.org/10.1002/14651858.CD000112.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD000112-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000112-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000112-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000112-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000112-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD000112-abs-0001" lang="en"> <section id="CD000112-sec-0001"> <h3 class="title" id="CD000112-sec-0001">Background</h3> <p>Because immunological aberrations might be the cause of miscarriage in some women, several immunotherapies have been used to treat women with otherwise unexplained recurrent pregnancy loss. </p> </section> <section id="CD000112-sec-0002"> <h3 class="title" id="CD000112-sec-0002">Objectives</h3> <p>The objective of this review was to assess the effects of any immunotherapy, including paternal leukocyte immunization and intravenous immunoglobulin on the live birth rate in women with previous unexplained recurrent miscarriages. </p> </section> <section id="CD000112-sec-0003"> <h3 class="title" id="CD000112-sec-0003">Search methods</h3> <p>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (11 February 2014) and reference lists of retrieved studies. </p> </section> <section id="CD000112-sec-0004"> <h3 class="title" id="CD000112-sec-0004">Selection criteria</h3> <p>Randomized trials of immunotherapies used to treat women with three or more prior miscarriages and no more than one live birth after, in whom all recognized non‐immunologic causes of recurrent miscarriage had been ruled out and no simultaneous treatment was given. </p> </section> <section id="CD000112-sec-0005"> <h3 class="title" id="CD000112-sec-0005">Data collection and analysis</h3> <p>The review author and the two co‐authors independently extracted data and assessed study quality for all studies considered for this review. </p> </section> <section id="CD000112-sec-0006"> <h3 class="title" id="CD000112-sec-0006">Main results</h3> <p>Twenty trials of high quality were included. The various forms of immunotherapy did not show significant differences between treatment and control groups in terms of subsequent live births: paternal cell immunization (12 trials, 641 women), Peto odds ratio (Peto OR) 1.23, 95% confidence interval (CI) 0.89 to 1.70; third‐party donor cell immunization (three trials, 156 women), Peto OR 1.39, 95% CI 0.68 to 2.82; trophoblast membrane infusion (one trial, 37 women), Peto OR 0.40, 95% CI 0.11 to 1.45; or intravenous immunoglobulin, (eight trials, 303 women), Peto OR 0.98, 95% CI 0.61 to 1.58. </p> </section> <section id="CD000112-sec-0007"> <h3 class="title" id="CD000112-sec-0007">Authors' conclusions</h3> <p>Paternal cell immunization, third‐party donor leukocytes, trophoblast membranes, and intravenous immunoglobulin provide no significant beneficial effect over placebo in improving the live birth rate. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD000112-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000112-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000112-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000112-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000112-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/ru#CD000112-abs-0005">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD000112-abs-0004" lang="en"> <h3>Immunotherapy for recurrent miscarriage</h3> <p>Immunotherapy does not lower the risk of future miscarriage in women who repeatedly miscarry. </p> <p><b>Background</b><br/> Recurrent miscarriage is three or more consecutive early miscarriages. One theory is that for some women, this might be caused by an immune system response to the embryo or fetus. Therapies that try to immunize the woman against the 'foreign' cells of a future pregnancy have been tried. Immunotherapies have included white blood cells (leukocytes) from the woman's partner or a donor, products derived from early embryos (trophoblast membranes), or antibodies derived from blood (immunoglobulin). </p> <p><b>Review question</b> <br/> We sought to determine whether immunological treatments would improve the chance of live births in women with a history of recurrent miscarriage.<br/> <br/> <b>Study characteristics</b><br/> We included 20 randomized controlled trials involving 1137 women, which took place from 1985 and 2004 in 11 countries. The trials examined four different forms of immunotherapy: immunization using white blood cells from the woman's partner (12 trials, 641 women), white blood cells from a third‐party donor (three trials, 156 women), products derived from early embryos (one trial, 37 women), or antibodies derived from blood (intravenous immunoglobulin) (eight trials 303 women). </p> <p><b>Quality of the evidence and conclusions</b><br/> Overall, we considered the risk of bias for the majority of included studies to be low. </p> <p>The review of trials found that none of these treatments provided a significant beneficial effect over placebo in improving the live birth rate or lowered the risk of future miscarriage in women who have recurrent miscarriages. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD000112-sec-0102" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD000112-sec-0102"></div> <h3 class="title" id="CD000112-sec-0103">Implications for practice</h3> <section id="CD000112-sec-0103"> <p>Neither immunization with paternal leukocytes nor treatment with intravenous immunoglobulin (IVIG) improve the live birth rate in women with unexplained recurrent miscarriage. Both are expensive and have potential serious side effects. Moreover, women should be spared the pain and grief associated with false expectations that an ineffective treatment might work. These therapies should no longer be offered as treatment for unexplained recurrent pregnancy loss. Furthermore, immunological laboratory tests, which have been previously been advocated as justification for immunotherapies, have no predictive value for pregnancy success and should be abandoned. </p> </section> <h3 class="title" id="CD000112-sec-0104">Implications for research</h3> <section id="CD000112-sec-0104"> <p>Effective treatment of an alleged alloimmune cause of recurrent miscarriage awaits more complete knowledge of the underlying pathophysiology. A specific assay to diagnose immune‐mediated early pregnancy loss and a reliable method to determine which women might benefit from manipulation of the maternal immune system are urgently needed. It is not presently known exactly how many recurrent early pregnancy losses are the result of anembryonic or chromosomally abnormal conceptuses, anatomic or structural abnormalities and how many are embryonic or fetal deaths. It is likely that some unexplained early losses are due to as yet undefined subchromosomal genetic abnormalities impairing early development of the conceptus (<a href="./references#CD000112-bbs2-0046" title="CoppAJ . Death before birth: clues from gene knockouts and mutations. Trends in Genetics1995;11(3):87‐93. ">Copp 1995</a>; <a href="./references#CD000112-bbs2-0062" title="PegoraroE , WhitakerJ , Mowery‐Ruston , SurtiU , LanasaM , HoffmanEP . Familial skewed X inactivation: a molecular trait associated with high spontaneous‐abortion rate maps to Xq28. American Journal of Human Genetics1997;61:160‐70. ">Pegoraro 1997</a>; <a href="./references#CD000112-bbs2-0063" title="QuenbyS , VinceG , FarquharsonR , AplinJ . Recurrent miscarriage: a defect in nature's quality control?. Human Reproduction2002;17(8):1959‐63. ">Quenby 2002</a>; <a href="./references#CD000112-bbs2-0065" title="RossantJ , CrossJC . Placental development: lessons from mouse mutants. Nature Reviews Genetics2001;2:538‐48. ">Rossant 2001</a>; <a href="./references#CD000112-bbs2-0071" title="SpandidosDA , KoumantakisE , SifakisS , SourvinosG . Microsatellite mutations in spontaneously aborted embryos. Fertility and Sterility1998;70(5):892‐5. ">Spandidos 1998</a>; <a href="./references#CD000112-bbs2-0073" title="TempferC , UnfriedG , ZeillingerR , HeflerL , NageleF , HuberJH . Endothelial nitric oxide synthase gene polymorphism in women with idiopathic recurrent miscarriage. Human Reproduction2001;16(8):1644‐7. ">Tempfer 2001</a>; <a href="./references#CD000112-bbs2-0074" title="TsaiAF , KaufmanKA , WalkerMA , KarrisonTG , OdemRB , BarnesRB , et al. Transmission disequilibrium of maternally‐inherited CTLA‐4 microsatellite alleles in idiopathic recurrent miscarriage. Journal of Reproductive Immunology1998;40(2):147‐57. ">Tsai 1998</a>). New molecular techniques should be directed at understanding the factors responsible for successful pregnancy as well as pregnancy loss. </p> <p>To establish definitively or to rule out the efficacy of any proposed treatment for recurrent pregnancy loss, randomized controlled trials with adequate numbers of participants are needed. These should be studies approved by institutional review boards in centers with research expertise and interest in this problem. New therapeutic modalities should be tested only under protocol with rigorous study designs. Finally, further studies on complications of treatment and long‐term follow‐up of offspring are necessary. The National Institutes of Health (NIH) in the United States and other funding agencies should be encouraged to support proposals that offer new and innovative approaches to this problem. The Agency of Health Care Policy and Research in the United States and similar funding agencies in other countries need to support proposals to evaluate outcome of treatments especially for large trials. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD000112-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD000112-sec-0022"></div> <section id="CD000112-sec-0023"> <h3 class="title" id="CD000112-sec-0023">Description of the condition</h3> <p>Approximately one to two per cent of couples experience recurrent pregnancy loss during the first trimester (<a href="./references#CD000112-bbs2-0047" title="CoulamCB . Epidemiology of recurrent spontaneous abortion. American Journal of Reproductive Immunology1991;26:23‐7. ">Coulam 1991</a>). Commonly defined as three or more consecutive miscarriages, recurrent miscarriage usually refers to those pregnancy losses occurring in the first trimester. This time limit is arbitrary and does not consider a variety of potential underlying causes of fetal death during the first half of pregnancy. Some couples who present for evaluation of recurrent miscarriage are found to have a disorder which is thought to be responsible for their pregnancy losses. However, the etiology of recurrent miscarriage remains elusive in the majority of women. It has been postulated that immunologic aberrations may be responsible for otherwise unexplained recurrent miscarriage. </p> <p>The physiological mechanisms that allow a mother to tolerate her semi‐allogeneic baby are unclear. Early reports proposed that human leukocyte (white blood cell) antigens compatibility of couples, the absence of maternal leukocytotoxic antibodies, or the absence of maternal blocking antibodies were related to recurrent miscarriage. Defects in molecular immunosuppressive factors (cytokines and growth factors) at the local decidual/trophoblast level have been implicated (<a href="./references#CD000112-bbs2-0056" title="HillJA . Immunological mechanisms of pregnancy maintenance and failure: a critique of theories and therapy. American Journal of Reproductive Immunology1990;22:33‐42. ">Hill 1990</a>; <a href="./references#CD000112-bbs2-0057" title="JohnsonPM . Pregnancy immunology. Fetal Maternal Medicine Review1992;4:1‐14. ">Johnson 1992</a>). Elevated serum levels of systemic natural killer (NK) cells have also been found in women having miscarriages of karyotypically normal pregnancies (<a href="./references#CD000112-bbs2-0044" title="ClarkDA , CoulamCB . Is there an immunological cause of repeated pregnancy wastage?. Advances in Obstetrics and Gynaecology1995;3:321‐42. ">Clark 1995</a>), and the presence of increased levels of NK cells in non‐pregnant women was associated with a higher probability of miscarriage in a subsequent pregnancy (<a href="./references#CD000112-bbs2-0042" title="AokiK , KajiuraS , MatsumotoY , OgasawaraM , OkadaS , YagamiY , et al. Preconceptional natural‐killer‐cell activity as a predictor of miscarriage. Lancet1995;345:1340‐2. ">Aoki 1995</a>; <a href="./references#CD000112-bbs2-0076" title="YamadaH , MorikawaM , KatoEH , ShimadaS , KobashiG , MinakamiH . Pre‐conceptional natural killer cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with normal chromosome karyotype. American Journal of Reproductive Immunology2003;50:351‐4. ">Yamada 2003</a>). Most recently, experimental models of miscarriage have focused on the placental milieu showing that pregnancy survival depends on inhibition of local inflammatory mediators (<a href="./references#CD000112-bbs2-0067" title="SalmonJE . A noninflammatory pathway of pregnancy loss: innate immune inactivation?. Journal of Clinical Investigation2004;114:15‐7. ">Salmon 2004</a>). Complement‐inhibitory proteins, maternal regulatory T‐cells, tryptophan catabolizing enzymes, and immunoregulatory cytokines may play a role in immunotolerance at the maternal‐fetal interface (<a href="./references#CD000112-bbs2-0041" title="AluvihareVR , KallikourdisM , BetzAG . Regulatory T cells mediate maternal tolerance to the fetus. Nature Immunology2004;5:266‐71. ">Aluvihare 2004</a>; <a href="./references#CD000112-bbs2-0059" title="MellorAL , SivakumarJ , ChandlerP , SmithK , MolinaH , MaoD , et al. Prevention of T cell‐driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nature Immunology2001;2:64‐8. ">Mellor 2001</a>; <a href="./references#CD000112-bbs2-0075" title="XuC , MaoD , HolersVM , PalancaB , ChengAM , MolinaH . A critical role for murine complement regulator crry in fetomaternal tolerance. Science2000;287:498‐501. ">Xu 2000</a>). </p> <p>Not all studies favor an alloimmune cause of recurrent miscarriage. Several studies have found little correlation between pregnancy outcome and histocompatibility, the presence of antipaternal leukocytotoxic or blocking antibodies (<a href="./references#CD000112-bbs2-0048" title="CoulamCB . Immunologic tests in the evaluation of reproductive disorders: a critical review. American Journal of Obstetrics and Gynecology1992;167:1844‐51. ">Coulam 1992</a>; <a href="./references#CD000112-bbs2-0068" title="ScottJR , RoteNS , BranchDW . Immunologic aspects or recurrent abortion and fetal death. Obstetrics &amp; Gynecology1987;70:645‐56. ">Scott 1987</a>; <a href="./references#CD000112-bbs2-0070" title="SmithJB , CowchockFS . Immunological studies in recurrent spontaneous abortion: effects of immunization of women with paternal mononuclear cells on lymphocytotoxic and mixed lymphocyte reaction blocking antibodies and correlation with sharing of HLA and pregnancy outcome. Journal of Reproductive Immunology1988;14:99‐113. ">Smith 1988</a>). Authorities point out that extrapolation from animal models may not be relevant in humans because of interspecies endocrine, immunologic, and reproductive differences, and the beneficial effect of pre‐transplant blood transfusions to ameliorate rejection has been questioned (<a href="./references#CD000112-bbs2-0069" title="ScottJR , BranchWD . Potential alloimmune factors and immunotherapy in recurrent miscarriage. Clinical Obstetrics and Gynecology1995;37:761‐7. ">Scott 1995</a>). The relationship of NK cell activity to pregnancy outcome has also been questioned (<a href="./references#CD000112-bbs2-0060" title="MorikawaM , YamadaH , KatoEH , ShimadaS , EbinaY , YamadaT , et al. NK cell activity and subsets in women with a history of spontaneous abortion. Cause, number of abortions, and subsequent pregnancy outcome. Gynecologic and Obstetric Investigation2001;52:163‐7. ">Morikawa 2001a</a>). </p> </section> <section id="CD000112-sec-0024"> <h3 class="title" id="CD000112-sec-0024">Description of the intervention</h3> <p>Several immunologic treatments have been advocated by some investigators, based on evidence that pre‐transplant blood transfusions decreased rejection of organ allografts. The most popular attempts at maternal immunomodulation have employed transfusion of paternal leukocytes (white blood cells ‐ lymphocytes) prior to conception or passive immunization with intravenous immunoglobulin (IVIG) during pregnancy. Other interventions include third‐party donor white cells or trophoblast membranes transfusions, although these have been largely abandoned because of doubts about efficacy. </p> </section> <section id="CD000112-sec-0025"> <h3 class="title" id="CD000112-sec-0025">How the intervention might work</h3> <p>The rationale for using IVIG to treat women with recurrent miscarriage is based on reports that it down regulates systemic NK cells (<a href="./references#CD000112-bbs2-0058" title="KwakJY , KwakFMY , AinbinderSW , RuizAM , BeerAG . Elevated peripheral blood natural killer cells are effectively suppressed by immunoglobulin G infusions in women with recurrent spontaneous abortion. American Journal of Reproductive Immunology1996;35(4):363‐9. ">Kwak 1996</a>; <a href="./references#CD000112-bbs2-0066" title="RuizJE , KwakJYH , BaumL , GilmansachsA , BeamanKD , KimYB , et al. Effects of intravenous immunoglobulin G on natural killer cell cytotoxicity in vitro in women with recurrent spontaneous abortion. Journal of Reproductive Immunology1996;31:125‐41. ">Ruiz 1996</a>) and abrogates NK cell activity at the implantation site (<a href="./references#CD000112-bbs2-0042" title="AokiK , KajiuraS , MatsumotoY , OgasawaraM , OkadaS , YagamiY , et al. Preconceptional natural‐killer‐cell activity as a predictor of miscarriage. Lancet1995;345:1340‐2. ">Aoki 1995</a>; <a href="./references#CD000112-bbs2-0061" title="MorikawaM , YamadaH , KatoEH , ShimadaS , KishiT , YamadaT , et al. Massive intravenous immunoglobulin treatment in women with four or more recurrent spontaneous abortions of unexplained etiology: down‐regulation of NK cell activity and subsets. American Journal of Reproductive Immunology2001;46:399‐404. ">Morikawa 2001b</a>). Immunization with paternal white cells or third‐party donor white cells has been postulated to prevent miscarriage in a similar manner as pre‐transplant blood transfusions to improve kidney graft survival. </p> </section> <section id="CD000112-sec-0026"> <h3 class="title" id="CD000112-sec-0026">Why it is important to do this review</h3> <p>This is an update of a Cochrane review first published in 2003, and previously updated in 2006. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD000112-sec-0027" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD000112-sec-0027"></div> <p>To determine whether immunologic treatments improve the chance of live births in women with a history of recurrent miscarriage. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD000112-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD000112-sec-0028"></div> <section id="CD000112-sec-0029"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD000112-sec-0030"> <h4 class="title">Types of studies</h4> <p>Randomized controlled trials that assessed the effect of immunologic treatments in women with recurrent miscarriages. Quasi‐randomized and cross‐over trials were excluded. </p> </section> <section id="CD000112-sec-0031"> <h4 class="title">Types of participants</h4> <p>Women with recurrent miscarriages who met the following criteria:</p> <p> <ol id="CD000112-list-0001"> <li> <p> three or more prior miscarriages and/or;</p> </li> <li> <p>no more than one prior live birth and/or;</p> </li> <li> <p>negative evaluations for non‐immunologic causes recurrent miscarriage that included:</p> <ol id="CD000112-list-0002"> <li> <p>normal parental karyotypes;</p> </li> <li> <p>antiphospholipid antibodies (lupus anticoagulant, anticardiolipin antibodies);</p> </li> <li> <p>abnormal uterine anatomy;</p> </li> <li> <p>luteal phase defect (as determined by endometrial biopsy or serum progesterone) and/or;</p> </li> </ol> </li> <li> <p>no simultaneous treatment or co‐intervention.</p> </li> </ol> </p> </section> <section id="CD000112-sec-0032"> <h4 class="title">Types of interventions</h4> <p>Immunization with leukocytes (paternal or third‐party donor) or trophoblast membrane, or intravenous immunoglobulin versus placebo or no treatment. </p> </section> <section id="CD000112-sec-0033"> <h4 class="title">Types of outcome measures</h4> <p>The primary outcome measure was a dichotomous variable defined as a live birth after 28 weeks' gestation in women receiving immunotherapy versus placebo/no treatment. In order to include the highest number of studies possible, this was expanded to include pregnancies alive after 20 weeks of gestation. </p> <section id="CD000112-sec-0034"> <h5 class="title">Primary outcomes</h5> <p>A live birth after 20 weeks' gestation in women receiving immunotherapy.</p> </section> <section id="CD000112-sec-0035"> <h5 class="title">Secondary outcomes</h5> <p>None.</p> </section> </section> </section> <section id="CD000112-sec-0036"> <h3 class="title">Search methods for identification of studies</h3> <p>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group. </p> <section id="CD000112-sec-0037"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Pregnancy and Childbirth Group trials register by contacting the Trials Search Co‐ordinator (11 February 2014). </p> <p>The Cochrane Pregnancy and Childbirth Group’s Trials Register is maintained by the Trials Search Co‐ordinator and contains trials identified from: </p> <p> <ol id="CD000112-list-0003"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE;</p> </li> <li> <p>weekly searches of Embase;</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Details of the search strategies for CENTRAL, MEDLINE and Embase, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the ‘Specialized Register’ section within the editorial information about the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html" target="_blank">Cochrane Pregnancy and Childbirth Group</a>. </p> <p>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co‐ordinator searches the register for each review using the topic list rather than keywords.  </p> <p>[For details of additional searching carried out in an earlier version of the review (<a href="./references#CD000112-bbs2-0077" title="PorterTF , LaCoursiereY , ScottJR . Immunotherapy for recurrent miscarriage. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD000112.pub2] ">Porter 2006</a>), please see <a href="./appendices#CD000112-sec-0108">Appendix 1</a>.] </p> </section> <section id="CD000112-sec-0038"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of retrieved studies.</p> <p>We did not apply any language restrictions.</p> </section> </section> <section id="CD000112-sec-0039"> <h3 class="title" id="CD000112-sec-0039">Data collection and analysis</h3> <p>For the methods used when assessing the trials identified in the previous version of this review, <i>see</i><a href="./references#CD000112-bbs2-0077" title="PorterTF , LaCoursiereY , ScottJR . Immunotherapy for recurrent miscarriage. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD000112.pub2] ">Porter 2006</a>. </p> <p>No new trials were included for this 2014 update. The following methods will be used in future updates. </p> <p>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group. </p> <section id="CD000112-sec-0040"> <h4 class="title">Selection of studies</h4> <p>Two review authors will independently assess for inclusion all the potential studies we identify as a result of the search strategy. We will resolve any disagreement through discussion or, if required, we will consult a third person. </p> </section> <section id="CD000112-sec-0041"> <h4 class="title">Data extraction and management</h4> <p>We will design a form to extract data. For eligible studies, at least two review authors will extract the data using the agreed form. We will resolve discrepancies through discussion or, if required, we will consult a third person. We will enter data into Review Manager software (<a href="./references#CD000112-bbs2-0064" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) and check for accuracy. </p> <p>When information regarding any of the above is unclear, we will attempt to contact authors of the original reports to provide further details. </p> </section> <section id="CD000112-sec-0042"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors will independently assess risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD000112-bbs2-0055" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We will resolve any disagreement by discussion or by involving a third assessor. </p> <section id="CD000112-sec-0043"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>We will describe for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We will assess the method as:</p> <p> <ul id="CD000112-list-0004"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD000112-sec-0044"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>We will describe for each included study the method used to conceal allocation to interventions prior to assignment and will assess whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We will assess the methods as:</p> <p> <ul id="CD000112-list-0005"> <li> <p>low risk of bias (e.g. telephone or central randomization; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD000112-sec-0045"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>We will describe for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We will consider that studies are at low risk of bias if they were blinded, or if we judge that the lack of blinding would be unlikely to affect results. We will assess blinding separately for different outcomes or classes of outcomes. </p> <p>We will assess the methods as:</p> <p> <ul id="CD000112-list-0006"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear risk of bias for personnel.</p> </li> </ul> </p> </section> <section id="CD000112-sec-0046"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>We will describe for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We will assess blinding separately for different outcomes or classes of outcomes. </p> <p>We will assess methods used to blind outcome assessment as:</p> <p> <ul id="CD000112-list-0007"> <li> <p>low, high or unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD000112-sec-0047"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>We will describe for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We will state whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomized participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information is reported, or can be supplied by the trial authors, we will re‐include missing data in the analyses which we undertake. </p> <p>We will assess methods as:</p> <p> <ul id="CD000112-list-0008"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomization); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD000112-sec-0048"> <h5 class="title">(5) Selective reporting (checking for reporting bias)</h5> <p>We will describe for each included study how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We will assess the methods as:</p> <p> <ul id="CD000112-list-0009"> <li> <p>low risk of bias (where it is clear that all of the study’s pre‐specified outcomes and all expected outcomes of interest to the review have been reported); </p> </li> <li> <p>high risk of bias (where not all the study’s pre‐specified outcomes have been reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD000112-sec-0049"> <h5 class="title">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>We will describe for each included study any important concerns we have about other possible sources of bias. </p> <p>We will assess whether each study was free of other problems that could put it at risk of bias: </p> <p> <ul id="CD000112-list-0010"> <li> <p>low risk of other bias;</p> </li> <li> <p>high risk of other bias;</p> </li> <li> <p>unclear whether there is risk of other bias.</p> </li> </ul> </p> </section> <section id="CD000112-sec-0050"> <h5 class="title">(7) Overall risk of bias</h5> <p>We will make explicit judgements about whether studies are at high risk of bias, according to the criteria given in the <i>Handbook</i> (<a href="./references#CD000112-bbs2-0055" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). With reference to (1) to (6) above, we will assess the likely magnitude and direction of the bias and whether we consider it is likely to impact on the findings. We will explore the impact of the level of bias through undertaking sensitivity analyses ‐ <i>see</i><a href="#CD000112-sec-0063">Sensitivity analysis</a>. </p> </section> </section> <section id="CD000112-sec-0051"> <h4 class="title">Measures of treatment effect</h4> <section id="CD000112-sec-0052"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we will present results as Peto odds ratio with 95% confidence intervals. </p> </section> <section id="CD000112-sec-0053"> <h5 class="title">Continuous data</h5> <p>Not applicable to the scope of our study.</p> </section> </section> <section id="CD000112-sec-0054"> <h4 class="title">Unit of analysis issues</h4> <p>Not applicable to the scope of our study.</p> <section id="CD000112-sec-0055"> <h5 class="title">Cluster‐randomized trials</h5> <p>We will include cluster‐randomized trials in the analyses along with individually‐randomized trials. We will adjust their sample sizes using the methods described in the <i>Handbook</i> using an estimate of the intracluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster‐randomized trials and individually‐randomized trials, we plan to synthesize the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomization unit is considered to be unlikely. </p> <p>We will also acknowledge heterogeneity in the randomization unit and perform a sensitivity analysis to investigate the effects of the randomization unit. </p> </section> <section id="CD000112-sec-0056"> <h5 class="title">Cross‐over trials</h5> <p>One included study (<a href="./references#CD000112-bbs2-0019" title="StephensonMD , DreherK , HoulihanE , WuV . Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double blinded, placebo controlled trial. American Journal of Reproductive Immunology1998;39:82‐8. ">Stephenson 1998</a>) had a cross‐over arm which was also double‐blinded that was not included in this review. </p> </section> <section id="CD000112-sec-0057"> <h5 class="title">Other unit of analysis issues</h5> <p>Not applicable.</p> </section> </section> <section id="CD000112-sec-0058"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, we will note levels of attrition. We will explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis. </p> <p>For all outcomes, we will carry out analyses, as far as possible, on an intention‐to‐treat basis, i.e. we will attempt to include all participants randomized to each group in the analyses, and all participants will be analyzed in the group to which they were allocated, regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial will be the number randomized minus any participants whose outcomes are known to be missing. </p> </section> <section id="CD000112-sec-0059"> <h4 class="title">Assessment of heterogeneity</h4> <p>We will assess statistical heterogeneity in each meta‐analysis using the Tau², I² and Chi² statistics. We will regard heterogeneity as substantial if an I² is greater than 30% and either a Tau² is greater than zero, or there is a low P value (less than 0.10) in the Chi² test for heterogeneity. </p> </section> <section id="CD000112-sec-0060"> <h4 class="title">Assessment of reporting biases</h4> <p>If there are 10 or more studies in the meta‐analysis, we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it. </p> </section> <section id="CD000112-sec-0061"> <h4 class="title">Data synthesis</h4> <p>We will carry out statistical analysis using the Review Manager software (<a href="./references#CD000112-bbs2-0064" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We will use fixed‐effect meta‐analysis for combining data where it is reasonable to assume that studies are estimating the same underlying treatment effect: i.e. where trials are examining the same intervention, and the trials’ populations and methods are judged sufficiently similar. If there is clinical heterogeneity sufficient to expect that the underlying treatment effects differ between trials, or if substantial statistical heterogeneity is detected, we will use random‐effects meta‐analysis to produce an overall summary, if an average treatment effect across trials is considered clinically meaningful. The random‐effects summary will be treated as the average of the range of possible treatment effects and we will discuss the clinical implications of treatment effects differing between trials. If the average treatment effect is not clinically meaningful, we will not combine trials. </p> <p>If we use random‐effects analyses, the results will be presented as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I². </p> </section> <section id="CD000112-sec-0062"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If we identify substantial heterogeneity, we will investigate it using subgroup analyses and sensitivity analyses. We will consider whether an overall summary is meaningful, and if it is, use random‐effects analysis to produce it. </p> <p>We plan to carry out the following subgroup analyses.</p> <p> <ul id="CD000112-list-0011"> <li> <p>Trials reporting data with intention‐to‐treat analysis.</p> </li> </ul> </p> <p>The following outcomes will be used in subgroup analysis.</p> <p> <ul id="CD000112-list-0012"> <li> <p>A live birth after 20 weeks' gestation in women receiving immunotherapy.</p> </li> </ul> </p> <p>We will assess subgroup differences by interaction tests available within RevMan (<a href="./references#CD000112-bbs2-0064" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We will report the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value. </p> </section> <section id="CD000112-sec-0063"> <h4 class="title">Sensitivity analysis</h4> <p>Sensitivity analyses will be performed for aspects of the review that might affect the results, such as high risk of bias for allocation concealment. Sensitivity analysis will be conducted by excluding studies at high risk of bias for allocation concealment from the analysis, to see if this makes any difference to the overall result. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD000112-sec-0064" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD000112-sec-0064"></div> <section id="CD000112-sec-0065"> <h3 class="title">Description of studies</h3> <p>A total of 15 studies were assessed for this update.</p> <section id="CD000112-sec-0066"> <h4 class="title">Results of the search</h4> <p>The updated search in February 2014 retrieved seven new studies. Eight studies were awaiting classification at the time of the last review (<a href="./references#CD000112-bbs2-0025" title="KilpatrickDC , KitchinAJ , ListonWA . Humoral immune response to lymphocyte antigens in early pregnancy and after leucocyte immunotherapy. Journal of Obstetrics and Gynaecology1993;13:77‐81. ">Kilpatrick 1993</a>; <a href="./references#CD000112-bbs2-0028" title="LiD , LiC , ZhuY . Comparative study of the third party and paternal leukocyte immunization in recurrent spontaneous abortion of lowered maternal‐fetal immuno‐recognition. Chinese Journal of Obstetrics and Gynecology1998;33:597‐600. ">Li 1998</a>; <a href="./references#CD000112-bbs2-0029" title="MahmoudF , DiejomaohM , OmuA , AbulH , HainesD . Effect of IgG therapy on lymphocyte subpopulations in the peripheral blood of Kuwaiti women experiencing recurrent pregnancy loss. Gynecologic and Obstetric Investigation2004;58(2):77‐83. ">Mahmoud 2004</a>; <a href="./references#CD000112-bbs2-0030" title="QuenbyS . A randomised controlled trial of prednisolone for women with recurrent miscarriage and high levels of uterine natural killer cells in the endometrium. Current Controlled Trials (www.controlled‐trials.com/) (accessed 30 October 2007). ">Quenby 2007</a>; <a href="./references#CD000112-bbs2-0032" title="SagotP , BignonJD , CesbronA , LaurentFX , AdjouC , MullerJY . Immunological treatment of spontaneous repeated abortions. The value of transfusing the partner's leukocytes in the third week of gestation. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1993;22:471‐5. ">Sagot 1993</a>; <a href="./references#CD000112-bbs2-0033" title="ScarpelliniF , SbraciaM . Use of granulocyte colony‐stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Human Reproduction2009;24(11):2703‐8. [PUBMED: 19617208] ">Scarpellini 2009</a>; <a href="./references#CD000112-bbs2-0035" title="StephensonM , HoulihanE , DayaS , ClamanP , GravesG , KuttehW . Intravenous immunoglobulin (IVIG) for treatment of unexplained secondary recurrent miscarriage: a prospective, randomized, double blinded, placebo‐controlled trial. Frontiers in Fetal Health2001;3(4):105‐6. ">Stephenson 2001</a>; <a href="./references#CD000112-bbs2-0037" title="TangAW , AlfirevicZ , TurnerMA , DruryJ , QuenbyS . Prednisolone Trial: Study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uNK) cells in the endometrium. Trials2009;10:102. ">Tang 2009</a>). Fourteen studies were excluded (<a href="./references#CD000112-bbs2-0025" title="KilpatrickDC , KitchinAJ , ListonWA . Humoral immune response to lymphocyte antigens in early pregnancy and after leucocyte immunotherapy. Journal of Obstetrics and Gynaecology1993;13:77‐81. ">Kilpatrick 1993</a>; <a href="./references#CD000112-bbs2-0026" title="KimCH , LeeKH , KimSH , ChaeHD , KangBM , JungKS . Effect of etanercept treatment in women with unexplained primary recurrent pregnancy loss. Human Reproduction2012;27(Suppl 2):P098. ">Kim 2012</a>; <a href="./references#CD000112-bbs2-0027" title="KwonSK , KimCH , AhnJW , LeeKH , ChaeHD , KangBM . Effect of intravenous immunoglobulin on pregnancy outcome following IVF/ICSI in infertile patients with endometriosis. Fertility and Sterility2012;98 Suppl 1(3):S263 Abstract no:O‐511. ">Kwon 2012</a>; <a href="./references#CD000112-bbs2-0028" title="LiD , LiC , ZhuY . Comparative study of the third party and paternal leukocyte immunization in recurrent spontaneous abortion of lowered maternal‐fetal immuno‐recognition. Chinese Journal of Obstetrics and Gynecology1998;33:597‐600. ">Li 1998</a>; <a href="./references#CD000112-bbs2-0029" title="MahmoudF , DiejomaohM , OmuA , AbulH , HainesD . Effect of IgG therapy on lymphocyte subpopulations in the peripheral blood of Kuwaiti women experiencing recurrent pregnancy loss. Gynecologic and Obstetric Investigation2004;58(2):77‐83. ">Mahmoud 2004</a>; <a href="./references#CD000112-bbs2-0030" title="QuenbyS . A randomised controlled trial of prednisolone for women with recurrent miscarriage and high levels of uterine natural killer cells in the endometrium. Current Controlled Trials (www.controlled‐trials.com/) (accessed 30 October 2007). ">Quenby 2007</a>; <a href="./references#CD000112-bbs2-0032" title="SagotP , BignonJD , CesbronA , LaurentFX , AdjouC , MullerJY . Immunological treatment of spontaneous repeated abortions. The value of transfusing the partner's leukocytes in the third week of gestation. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1993;22:471‐5. ">Sagot 1993</a>; <a href="./references#CD000112-bbs2-0033" title="ScarpelliniF , SbraciaM . Use of granulocyte colony‐stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Human Reproduction2009;24(11):2703‐8. [PUBMED: 19617208] ">Scarpellini 2009</a>; <a href="./references#CD000112-bbs2-0034" title="ScarpelliniF , SbraciaM . Granulocyte colony‐stimulating factor for the treatment of recurrent miscarriage. Journal of Reproductive Immunology2011;90(2):158‐9. ">Scarpellini 2011</a>; <a href="./references#CD000112-bbs2-0035" title="StephensonM , HoulihanE , DayaS , ClamanP , GravesG , KuttehW . Intravenous immunoglobulin (IVIG) for treatment of unexplained secondary recurrent miscarriage: a prospective, randomized, double blinded, placebo‐controlled trial. Frontiers in Fetal Health2001;3(4):105‐6. ">Stephenson 2001</a>; <a href="./references#CD000112-bbs2-0036" title="StephensonMD , KuttehWH , PurkissS , LibrachC , SchultzP , HoulihanE , et al. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo‐controlled trial. Human Reproduction2010;25(9):2203‐9. ">Stephenson 2010</a>; <a href="./references#CD000112-bbs2-0037" title="TangAW , AlfirevicZ , TurnerMA , DruryJ , QuenbyS . Prednisolone Trial: Study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uNK) cells in the endometrium. Trials2009;10:102. ">Tang 2009</a>; <a href="./references#CD000112-bbs2-0038" title="TangAW , AlfirevicZ , TurnerMA , DruryJ , ToppingJ , DawoodF , et al. A pilot, double blind randomised controlled trial of prednisolone for women with recurrent miscarriage and raised uterine natural killer cell density. Human Reproduction2011;26(Suppl 1):i48‐9. ">Tang 2011</a>; <a href="./references#CD000112-bbs2-0039" title="TangAW , AlfirevicZ , TurnerMA , DruryJA , SmallR , QuenbyS . A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant. Human Reproduction2013;28(7):1743‐52. ">Tang 2013</a>) and one is awaiting translation (<a href="./references#CD000112-bbs2-0040" title="SunX‐G , LiuX‐Y , ZhuR , FanG‐S , ZhangY , ChenF‐L . Effectiveness of intravenous immunoglobulin therapy in treating unexplained recurrent spontaneous abortion and its effect on the level of serum soluble human leucocyte antigen G. Acta Academiae Medicinae Sinicae2010;32(5):483‐7. ">Sun 2010</a>). </p> </section> <section id="CD000112-sec-0067"> <h4 class="title">Included studies</h4> <p>Twenty randomized controlled trials were included.</p> <p>The included studies were categorized according to the type of intervention, as listed below. </p> <section id="CD000112-sec-0068"> <h5 class="title">(A) Paternal cell immunization</h5> <section id="CD000112-sec-0069"> <h6 class="title">Published trials</h6> <p> <ol id="CD000112-list-0013"> <li> <p><a href="./references#CD000112-bbs2-0001" title="CauchiMN . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:263. CauchiMN , LimD , YoungDE , KlossM , PepperellRJ . Treatment of recurrent aborters by immunization with paternal cells ‐ controlled trial. American Journal of Reproductive Immunology1991;25:16‐7. ">Cauchi 1991</a>* </p> </li> <li> <p><a href="./references#CD000112-bbs2-0006" title="GatenbyPA . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:263‐4. GatenbyPA , CameronK , SimesRJ , AdelsteinS , BennettMJ , JansenRPS , et al. Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: results of a controlled trial. American Journal of Reproductive Immunology1993;29:88‐94. ">Gatenby 1993</a>* </p> </li> <li> <p><a href="./references#CD000112-bbs2-0008" title="HoHN , GillTJ . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:269‐70. HoHN , GillTJ , HsiehHJ , JiangJJ , LeeTY , HsiehCY . Immunotherapy for recurrent spontaneous abortions in a Chinese population. American Journal of Reproductive Immunology1991;25:10‐5. ">Ho 1991</a>* </p> </li> <li> <p><a href="./references#CD000112-bbs2-0013" title="MowbrayJF , GibbingsC , LiddellH , ReginaldPW , UnderwoodJL , BeardRW . Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells. Lancet1985;1:941‐3. MowbrayJF , UnderwoodJL . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:261. ">Mowbray 1985</a> </p> </li> <li> <p><a href="./references#CD000112-bbs2-0009" title="IlleniMT , MarelliG , ParazziniF , AcaiaB , BoccioloneL , BontempelliM , et al. Immunotherapy and recurrent abortion: a randomized clinical trial. Human Reproduction1994;9:1247‐9. ParazziniF . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:265. ">Illeni 1994</a>* </p> </li> <li> <p><a href="./references#CD000112-bbs2-0014" title="KarrisonTG , OberC . Recurrent miscarriage (remis) study: how should data from women who do not become pregnant be handled?. Controlled Clinical Trials1998;19:430‐9. OberC , KarrisonT , OdemRB , BarnesRB , BranchDW , StephensonMD . Mononuclear‐cell immunisation in prevention of recurrent miscarriages: a randomised trial. Lancet1999;354:365‐9. ">Ober 1999</a> </p> </li> <li> <p><a href="./references#CD000112-bbs2-0015" title="PandeyMK , AgrawalS . Induction of MLR‐Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion. International Immunopharmacology2004;4:289‐98. PandeyMK , ThakurS , AgrawalS . Lymphocyte immunotherapy and its probable mechanism in the maintenance of pregnancy in women with recurrent spontaneous abortion. Archives of Gynecology and Obstetrics2004;269:161‐72. ">Pandey 2004</a> </p> </li> </ol> </p> </section> <section id="CD000112-sec-0070"> <h6 class="title">Unpublished trials</h6> <p> <ol id="CD000112-list-0014"> <li> <p><a href="./references#CD000112-bbs2-0002" title="ChristiansenOB , ChristiansenBS , HusthM , MathiesenO , LauritsenJ , GrunnetN . Prospective study of anticardiolipin antibodies in immunized and untreated women with recurrent spontaneous abortions. Fertility and Sterility1992;58:328‐34. ChristiansenOB , MathiesenO , HusthM , LauritsenJG , GrunnetJ . Placebo‐controlled trial of active immunization with third party leukocytes in recurrent miscarriage. Acta Obstetricia et Gynecologica Scandinavica1994;3:261‐8. ">Christiansen 1994</a>* </p> </li> <li> <p><a href="./references#CD000112-bbs2-0012" title="KilpatrickDC . Department of Transfusion Medicine, The Royal Infirmary, Edinburgh EH3 9HB, Scotland. Personal communication1994. KilpatrickDC , ListonW . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:264. ">Kilpatrick 1994</a>* </p> </li> <li> <p><a href="./references#CD000112-bbs2-0017" title="ReznikoffMF . INTS [Laboratoire], 6 rue Cabanel, 75015 Paris, France. Personal communication1994. Reznikoff‐EtievantMF . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:266‐7. ">Reznikoff 1994</a>* </p> </li> <li> <p><a href="./references#CD000112-bbs2-0020" title="Stray‐PedersonS . Department of Obstetrics and Gynecology, University of Oslo, Oslo, 1 Norway. Personal communication1994. ">Stray‐Pederson 1994</a> </p> </li> <li> <p><a href="./references#CD000112-bbs2-0018" title="ScottJR , BranchWD , DudleyD . Department of Obstetrics and Gynecology, University of Utah Medical Center, Salt Lake City, Utah 84132, USA. Personal communication1994. ScottJR , BranchWD , DudleyDJ , HatasakaHH . Immunotherapy for recurrent pregnancy loss: the University of Utah perspective. In: DonderoF , JohnsonP editor(s). Reproductive Immunology. Serono Symposium Publications, Raven Press, 1997:255‐7. ">Scott 1994</a>* </p> </li> </ol> </p> </section> </section> <section id="CD000112-sec-0071"> <h5 class="title">(B) Third‐party donor cell immunization</h5> <section id="CD000112-sec-0072"> <h6 class="title">Published trials</h6> <p> <ol id="CD000112-list-0015"> <li> <p><a href="./references#CD000112-bbs2-0002" title="ChristiansenOB , ChristiansenBS , HusthM , MathiesenO , LauritsenJ , GrunnetN . Prospective study of anticardiolipin antibodies in immunized and untreated women with recurrent spontaneous abortions. Fertility and Sterility1992;58:328‐34. ChristiansenOB , MathiesenO , HusthM , LauritsenJG , GrunnetJ . Placebo‐controlled trial of active immunization with third party leukocytes in recurrent miscarriage. Acta Obstetricia et Gynecologica Scandinavica1994;3:261‐8. ">Christiansen 1994</a>* </p> </li> <li> <p><a href="./references#CD000112-bbs2-0008" title="HoHN , GillTJ . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:269‐70. HoHN , GillTJ , HsiehHJ , JiangJJ , LeeTY , HsiehCY . Immunotherapy for recurrent spontaneous abortions in a Chinese population. American Journal of Reproductive Immunology1991;25:10‐5. ">Ho 1991</a>* </p> </li> </ol> </p> </section> <section id="CD000112-sec-0073"> <h6 class="title">Unpublished trials</h6> <p> <ol id="CD000112-list-0016"> <li> <p><a href="./references#CD000112-bbs2-0018" title="ScottJR , BranchWD , DudleyD . Department of Obstetrics and Gynecology, University of Utah Medical Center, Salt Lake City, Utah 84132, USA. Personal communication1994. ScottJR , BranchWD , DudleyDJ , HatasakaHH . Immunotherapy for recurrent pregnancy loss: the University of Utah perspective. In: DonderoF , JohnsonP editor(s). Reproductive Immunology. Serono Symposium Publications, Raven Press, 1997:255‐7. ">Scott 1994</a>* </p> </li> </ol> </p> </section> </section> <section id="CD000112-sec-0074"> <h5 class="title">(C) Trophoblast membrane immunization</h5> <section id="CD000112-sec-0075"> <h6 class="title">Published trials</h6> <p> <ol id="CD000112-list-0017"> <li> <p><a href="./references#CD000112-bbs2-0011" title="JohnsonPM , RamsdenGH , ChiaKV , HartCA , FarquharsonRG , FrancisWJA . A combined randomised double‐blind and open study of trophoblast membrane infusion (TMI) in unexplained recurrent miscarriage. In: ChaouatG , MowbrayJ editor(s). Cellular Molecular Biology of the Materno‐Fetal Relationship. Vol. 212, Colloque INSERM/John Libbey Eurotext Ltd, 1991:277‐84. ">Johnson 1991</a> </p> </li> </ol> </p> </section> </section> <section id="CD000112-sec-0076"> <h5 class="title">(D) Intravenous immunoglobulin</h5> <section id="CD000112-sec-0077"> <h6 class="title">Published trials</h6> <p> <ol id="CD000112-list-0018"> <li> <p><a href="./references#CD000112-bbs2-0003" title="ChristiansenOB , MathiesenO , HusthM . Intravenous immunoglobulin treatment of women with recurrent miscarriage. Acta Obstetricia et Gynecologica Scandinavica1997;76:2. ChristiansenOB , MathiesonO , HusthM , RasmussenK , IngerslevJH , LauritsenJG , et al. Placebo‐controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with iv immunoglobulin. Human Reproduction1995;10:2690‐5. ">Christiansen 1995</a>* </p> </li> <li> <p><a href="./references#CD000112-bbs2-0005" title="CoulamCB . Alternative treatment to lymphocyte immunization for treatment of recurrent spontaneous abortion. Immunotherapy with intravenous immunoglobulin for treatment of recurrent pregnancy loss: American experience. American Journal of Reproductive Immunology1994;32:286‐9. CoulamCB . Immunotherapy with intravenous immunoglobulin for treatment of recurrent pregnancy loss: American experience. International Journal of Gynecology and Obstetrics1994;46:47. CoulamCB , KrysaL , SternJJ , BustilloM . Intravenous immunoglobulin for treatment of recurrent pregnancy loss. American Journal of Reproductive Immunology1995;34:333‐7. CoulamCB , SternJJ , BustilloM . Ultrasonographic findings of pregnancy losses after treatment for recurrent pregnancy loss: intravenous immunoglobulin vs placebo. Fertility and Sterility1994;61:248‐51. ">Coulam 1995</a>* </p> </li> <li> <p><a href="./references#CD000112-bbs2-0007" title="German RSA/IVIG Group. Intravenous immunoglobulin for treatment of recurrent miscarriage. British Journal of Obstetrics and Gynaecology1994;101:1072‐7. ">German RSA/IVIG 1994</a>* </p> </li> <li> <p><a href="./references#CD000112-bbs2-0019" title="StephensonMD , DreherK , HoulihanE , WuV . Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double blinded, placebo controlled trial. American Journal of Reproductive Immunology1998;39:82‐8. ">Stephenson 1998</a>* </p> </li> <li> <p><a href="./references#CD000112-bbs2-0016" title="PerinoA , VassiliadisA , VucetichaR , ColacurciN , MenatoG , CignittiM , et al. Short‐term therapy for recurrent abortion using intravenous immunoglobulins: results of a double‐blind placebo‐controlled Italian study. Human Reproduction1997;12:2388‐92. ">Perino 1997</a> </p> </li> <li> <p><a href="./references#CD000112-bbs2-0010" title="JablonowskaB , SelbingA , PalfiM , ErnerudhJ , KjellbergS , LindtonB . Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double‐blind placebo‐controlled study. Human Reproduction1999;14:838‐41. ">Jablonowska 1999</a> </p> </li> <li> <p><a href="./references#CD000112-bbs2-0004" title="ChristiansenOB , PedersenB , RosgaardA , Husth . A randomized, double‐blind, placebo‐controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage. Human Reproduction2002;17(3):809‐16. ">Christiansen 2002</a> </p> </li> </ol> </p> <p>* Individual patient data sheets also reviewed</p> </section> </section> <section id="CD000112-sec-0078"> <h5 class="title">Settings</h5> <p>These studies were reported between 1985 and 2004 in 11 countries: Australia (<a href="./references#CD000112-bbs2-0001" title="CauchiMN . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:263. CauchiMN , LimD , YoungDE , KlossM , PepperellRJ . Treatment of recurrent aborters by immunization with paternal cells ‐ controlled trial. American Journal of Reproductive Immunology1991;25:16‐7. ">Cauchi 1991</a>, <a href="./references#CD000112-bbs2-0006" title="GatenbyPA . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:263‐4. GatenbyPA , CameronK , SimesRJ , AdelsteinS , BennettMJ , JansenRPS , et al. Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: results of a controlled trial. American Journal of Reproductive Immunology1993;29:88‐94. ">Gatenby 1993</a>); Canada (<a href="./references#CD000112-bbs2-0014" title="KarrisonTG , OberC . Recurrent miscarriage (remis) study: how should data from women who do not become pregnant be handled?. Controlled Clinical Trials1998;19:430‐9. OberC , KarrisonT , OdemRB , BarnesRB , BranchDW , StephensonMD . Mononuclear‐cell immunisation in prevention of recurrent miscarriages: a randomised trial. Lancet1999;354:365‐9. ">Ober 1999</a>; <a href="./references#CD000112-bbs2-0019" title="StephensonMD , DreherK , HoulihanE , WuV . Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double blinded, placebo controlled trial. American Journal of Reproductive Immunology1998;39:82‐8. ">Stephenson 1998</a>); Denmark (<a href="./references#CD000112-bbs2-0002" title="ChristiansenOB , ChristiansenBS , HusthM , MathiesenO , LauritsenJ , GrunnetN . Prospective study of anticardiolipin antibodies in immunized and untreated women with recurrent spontaneous abortions. Fertility and Sterility1992;58:328‐34. ChristiansenOB , MathiesenO , HusthM , LauritsenJG , GrunnetJ . Placebo‐controlled trial of active immunization with third party leukocytes in recurrent miscarriage. Acta Obstetricia et Gynecologica Scandinavica1994;3:261‐8. ">Christiansen 1994</a>,<a href="./references#CD000112-bbs2-0003" title="ChristiansenOB , MathiesenO , HusthM . Intravenous immunoglobulin treatment of women with recurrent miscarriage. Acta Obstetricia et Gynecologica Scandinavica1997;76:2. ChristiansenOB , MathiesonO , HusthM , RasmussenK , IngerslevJH , LauritsenJG , et al. Placebo‐controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with iv immunoglobulin. Human Reproduction1995;10:2690‐5. ">Christiansen 1995</a>, <a href="./references#CD000112-bbs2-0004" title="ChristiansenOB , PedersenB , RosgaardA , Husth . A randomized, double‐blind, placebo‐controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage. Human Reproduction2002;17(3):809‐16. ">Christiansen 2002</a>); France (<a href="./references#CD000112-bbs2-0017" title="ReznikoffMF . INTS [Laboratoire], 6 rue Cabanel, 75015 Paris, France. Personal communication1994. Reznikoff‐EtievantMF . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:266‐7. ">Reznikoff 1994)</a>; Germany (<a href="./references#CD000112-bbs2-0007" title="German RSA/IVIG Group. Intravenous immunoglobulin for treatment of recurrent miscarriage. British Journal of Obstetrics and Gynaecology1994;101:1072‐7. ">German RSA/IVIG 1994</a>); Italy (<a href="./references#CD000112-bbs2-0009" title="IlleniMT , MarelliG , ParazziniF , AcaiaB , BoccioloneL , BontempelliM , et al. Immunotherapy and recurrent abortion: a randomized clinical trial. Human Reproduction1994;9:1247‐9. ParazziniF . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:265. ">Illeni 1994</a>; <a href="./references#CD000112-bbs2-0016" title="PerinoA , VassiliadisA , VucetichaR , ColacurciN , MenatoG , CignittiM , et al. Short‐term therapy for recurrent abortion using intravenous immunoglobulins: results of a double‐blind placebo‐controlled Italian study. Human Reproduction1997;12:2388‐92. ">Perino 1997</a>); Norway (<a href="./references#CD000112-bbs2-0020" title="Stray‐PedersonS . Department of Obstetrics and Gynecology, University of Oslo, Oslo, 1 Norway. Personal communication1994. ">Stray‐Pederson 1994</a>); Sweden (<a href="./references#CD000112-bbs2-0010" title="JablonowskaB , SelbingA , PalfiM , ErnerudhJ , KjellbergS , LindtonB . Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double‐blind placebo‐controlled study. Human Reproduction1999;14:838‐41. ">Jablonowska 1999</a>); Taiwan (<a href="./references#CD000112-bbs2-0008" title="HoHN , GillTJ . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:269‐70. HoHN , GillTJ , HsiehHJ , JiangJJ , LeeTY , HsiehCY . Immunotherapy for recurrent spontaneous abortions in a Chinese population. American Journal of Reproductive Immunology1991;25:10‐5. ">Ho 1991</a>); United Kingdom (<a href="./references#CD000112-bbs2-0011" title="JohnsonPM , RamsdenGH , ChiaKV , HartCA , FarquharsonRG , FrancisWJA . A combined randomised double‐blind and open study of trophoblast membrane infusion (TMI) in unexplained recurrent miscarriage. In: ChaouatG , MowbrayJ editor(s). Cellular Molecular Biology of the Materno‐Fetal Relationship. Vol. 212, Colloque INSERM/John Libbey Eurotext Ltd, 1991:277‐84. ">Johnson 1991</a>; <a href="./references#CD000112-bbs2-0012" title="KilpatrickDC . Department of Transfusion Medicine, The Royal Infirmary, Edinburgh EH3 9HB, Scotland. Personal communication1994. KilpatrickDC , ListonW . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:264. ">Kilpatrick 1994</a>; <a href="./references#CD000112-bbs2-0013" title="MowbrayJF , GibbingsC , LiddellH , ReginaldPW , UnderwoodJL , BeardRW . Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells. Lancet1985;1:941‐3. MowbrayJF , UnderwoodJL . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:261. ">Mowbray 1985</a>); and USA (<a href="./references#CD000112-bbs2-0005" title="CoulamCB . Alternative treatment to lymphocyte immunization for treatment of recurrent spontaneous abortion. Immunotherapy with intravenous immunoglobulin for treatment of recurrent pregnancy loss: American experience. American Journal of Reproductive Immunology1994;32:286‐9. CoulamCB . Immunotherapy with intravenous immunoglobulin for treatment of recurrent pregnancy loss: American experience. International Journal of Gynecology and Obstetrics1994;46:47. CoulamCB , KrysaL , SternJJ , BustilloM . Intravenous immunoglobulin for treatment of recurrent pregnancy loss. American Journal of Reproductive Immunology1995;34:333‐7. CoulamCB , SternJJ , BustilloM . Ultrasonographic findings of pregnancy losses after treatment for recurrent pregnancy loss: intravenous immunoglobulin vs placebo. Fertility and Sterility1994;61:248‐51. ">Coulam 1995</a>; <a href="./references#CD000112-bbs2-0014" title="KarrisonTG , OberC . Recurrent miscarriage (remis) study: how should data from women who do not become pregnant be handled?. Controlled Clinical Trials1998;19:430‐9. OberC , KarrisonT , OdemRB , BarnesRB , BranchDW , StephensonMD . Mononuclear‐cell immunisation in prevention of recurrent miscarriages: a randomised trial. Lancet1999;354:365‐9. ">Ober 1999</a>; <a href="./references#CD000112-bbs2-0015" title="PandeyMK , AgrawalS . Induction of MLR‐Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion. International Immunopharmacology2004;4:289‐98. PandeyMK , ThakurS , AgrawalS . Lymphocyte immunotherapy and its probable mechanism in the maintenance of pregnancy in women with recurrent spontaneous abortion. Archives of Gynecology and Obstetrics2004;269:161‐72. ">Pandey 2004</a>; <a href="./references#CD000112-bbs2-0018" title="ScottJR , BranchWD , DudleyD . Department of Obstetrics and Gynecology, University of Utah Medical Center, Salt Lake City, Utah 84132, USA. Personal communication1994. ScottJR , BranchWD , DudleyDJ , HatasakaHH . Immunotherapy for recurrent pregnancy loss: the University of Utah perspective. In: DonderoF , JohnsonP editor(s). Reproductive Immunology. Serono Symposium Publications, Raven Press, 1997:255‐7. ">Scott 1994</a>). </p> </section> <section id="CD000112-sec-0079"> <h5 class="title">Participants</h5> <p>All of the included studies recruited women with at least three or more prior miscarriages, no more than one prior live birth, a negative evaluation for non‐immunologic causes of recurrent miscarriage (normal parental chromosomes, normal maternal uterine anatomy), and not known to have antiphospholipid antibodies. Only four trials included women with only primary recurrent miscarriages and excluded women with secondary recurrent miscarriage (<a href="./references#CD000112-bbs2-0007" title="German RSA/IVIG Group. Intravenous immunoglobulin for treatment of recurrent miscarriage. British Journal of Obstetrics and Gynaecology1994;101:1072‐7. ">German RSA/IVIG 1994</a>; <a href="./references#CD000112-bbs2-0009" title="IlleniMT , MarelliG , ParazziniF , AcaiaB , BoccioloneL , BontempelliM , et al. Immunotherapy and recurrent abortion: a randomized clinical trial. Human Reproduction1994;9:1247‐9. ParazziniF . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:265. ">Illeni 1994</a>; <a href="./references#CD000112-bbs2-0016" title="PerinoA , VassiliadisA , VucetichaR , ColacurciN , MenatoG , CignittiM , et al. Short‐term therapy for recurrent abortion using intravenous immunoglobulins: results of a double‐blind placebo‐controlled Italian study. Human Reproduction1997;12:2388‐92. ">Perino 1997</a>; <a href="./references#CD000112-bbs2-0017" title="ReznikoffMF . INTS [Laboratoire], 6 rue Cabanel, 75015 Paris, France. Personal communication1994. Reznikoff‐EtievantMF . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:266‐7. ">Reznikoff 1994</a>). </p> </section> <section id="CD000112-sec-0080"> <h5 class="title">Interventions</h5> <p>Interventions studied include immunization with leukocytes (paternal or third‐party donor) or trophoblast membrane, or intravenous immunoglobulin versus placebo or no treatment. Any trials in which there was simultaneous treatment or co‐intervention were excluded. </p> <p>There was no consistency among the trials with regards to timing of treatment initiation, duration, or dose. Among trials examining paternal cell immunization, treatment was administered prior to pregnancy in all trials except <a href="./references#CD000112-bbs2-0012" title="KilpatrickDC . Department of Transfusion Medicine, The Royal Infirmary, Edinburgh EH3 9HB, Scotland. Personal communication1994. KilpatrickDC , ListonW . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:264. ">Kilpatrick 1994</a>, where treatment was given prior to pregnancy with an additional treatment dose given after conception, and <a href="./references#CD000112-bbs2-0001" title="CauchiMN . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:263. CauchiMN , LimD , YoungDE , KlossM , PepperellRJ . Treatment of recurrent aborters by immunization with paternal cells ‐ controlled trial. American Journal of Reproductive Immunology1991;25:16‐7. ">Cauchi 1991</a>, where treatment was administered once pregnancy was established. With regards to trials of third‐party cell immunization, both <a href="./references#CD000112-bbs2-0002" title="ChristiansenOB , ChristiansenBS , HusthM , MathiesenO , LauritsenJ , GrunnetN . Prospective study of anticardiolipin antibodies in immunized and untreated women with recurrent spontaneous abortions. Fertility and Sterility1992;58:328‐34. ChristiansenOB , MathiesenO , HusthM , LauritsenJG , GrunnetJ . Placebo‐controlled trial of active immunization with third party leukocytes in recurrent miscarriage. Acta Obstetricia et Gynecologica Scandinavica1994;3:261‐8. ">Christiansen 1994</a>, <a href="./references#CD000112-bbs2-0008" title="HoHN , GillTJ . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:269‐70. HoHN , GillTJ , HsiehHJ , JiangJJ , LeeTY , HsiehCY . Immunotherapy for recurrent spontaneous abortions in a Chinese population. American Journal of Reproductive Immunology1991;25:10‐5. ">Ho 1991</a>, and <a href="./references#CD000112-bbs2-0018" title="ScottJR , BranchWD , DudleyD . Department of Obstetrics and Gynecology, University of Utah Medical Center, Salt Lake City, Utah 84132, USA. Personal communication1994. ScottJR , BranchWD , DudleyDJ , HatasakaHH . Immunotherapy for recurrent pregnancy loss: the University of Utah perspective. In: DonderoF , JohnsonP editor(s). Reproductive Immunology. Serono Symposium Publications, Raven Press, 1997:255‐7. ">Scott 1994</a> administered treatment prior to pregnancy. <a href="./references#CD000112-bbs2-0011" title="JohnsonPM , RamsdenGH , ChiaKV , HartCA , FarquharsonRG , FrancisWJA . A combined randomised double‐blind and open study of trophoblast membrane infusion (TMI) in unexplained recurrent miscarriage. In: ChaouatG , MowbrayJ editor(s). Cellular Molecular Biology of the Materno‐Fetal Relationship. Vol. 212, Colloque INSERM/John Libbey Eurotext Ltd, 1991:277‐84. ">Johnson 1991</a> examined the utility of trophoblast membrane immunization prior to pregnancy. The majority of trials investigating the utility of intravenous immunoglobulin were performed once pregnancy had been established. The exception are <a href="./references#CD000112-bbs2-0019" title="StephensonMD , DreherK , HoulihanE , WuV . Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double blinded, placebo controlled trial. American Journal of Reproductive Immunology1998;39:82‐8. ">Stephenson 1998</a>, which studied intravenous immunoglobulin treatment prior to pregnancy and <a href="./references#CD000112-bbs2-0005" title="CoulamCB . Alternative treatment to lymphocyte immunization for treatment of recurrent spontaneous abortion. Immunotherapy with intravenous immunoglobulin for treatment of recurrent pregnancy loss: American experience. American Journal of Reproductive Immunology1994;32:286‐9. CoulamCB . Immunotherapy with intravenous immunoglobulin for treatment of recurrent pregnancy loss: American experience. International Journal of Gynecology and Obstetrics1994;46:47. CoulamCB , KrysaL , SternJJ , BustilloM . Intravenous immunoglobulin for treatment of recurrent pregnancy loss. American Journal of Reproductive Immunology1995;34:333‐7. CoulamCB , SternJJ , BustilloM . Ultrasonographic findings of pregnancy losses after treatment for recurrent pregnancy loss: intravenous immunoglobulin vs placebo. Fertility and Sterility1994;61:248‐51. ">Coulam 1995</a> which initiated intravenous immunoglobulin treatment prior to pregnancy and continued its use throughout pregnancy. </p> <p>Like treatment timing and duration, there was great heterogeneity in the mode of treatment administration. The majority of trials administered intervention intravenously, although some also administered treatment intramuscularly and subcutaneously. </p> </section> <section id="CD000112-sec-0081"> <h5 class="title">Outcomes</h5> <p>The primary outcome measure was a dichotomous variable defined as a live birth after 28 weeks’ gestation in women receiving immunotherapy versus placebo/no treatment (<a href="./references#CD000112-bbs2-0002" title="ChristiansenOB , ChristiansenBS , HusthM , MathiesenO , LauritsenJ , GrunnetN . Prospective study of anticardiolipin antibodies in immunized and untreated women with recurrent spontaneous abortions. Fertility and Sterility1992;58:328‐34. ChristiansenOB , MathiesenO , HusthM , LauritsenJG , GrunnetJ . Placebo‐controlled trial of active immunization with third party leukocytes in recurrent miscarriage. Acta Obstetricia et Gynecologica Scandinavica1994;3:261‐8. ">Christiansen 1994</a>; <a href="./references#CD000112-bbs2-0003" title="ChristiansenOB , MathiesenO , HusthM . Intravenous immunoglobulin treatment of women with recurrent miscarriage. Acta Obstetricia et Gynecologica Scandinavica1997;76:2. ChristiansenOB , MathiesonO , HusthM , RasmussenK , IngerslevJH , LauritsenJG , et al. Placebo‐controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with iv immunoglobulin. Human Reproduction1995;10:2690‐5. ">Christiansen 1995</a>; <a href="./references#CD000112-bbs2-0004" title="ChristiansenOB , PedersenB , RosgaardA , Husth . A randomized, double‐blind, placebo‐controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage. Human Reproduction2002;17(3):809‐16. ">Christiansen 2002</a>; <a href="./references#CD000112-bbs2-0005" title="CoulamCB . Alternative treatment to lymphocyte immunization for treatment of recurrent spontaneous abortion. Immunotherapy with intravenous immunoglobulin for treatment of recurrent pregnancy loss: American experience. American Journal of Reproductive Immunology1994;32:286‐9. CoulamCB . Immunotherapy with intravenous immunoglobulin for treatment of recurrent pregnancy loss: American experience. International Journal of Gynecology and Obstetrics1994;46:47. CoulamCB , KrysaL , SternJJ , BustilloM . Intravenous immunoglobulin for treatment of recurrent pregnancy loss. American Journal of Reproductive Immunology1995;34:333‐7. CoulamCB , SternJJ , BustilloM . Ultrasonographic findings of pregnancy losses after treatment for recurrent pregnancy loss: intravenous immunoglobulin vs placebo. Fertility and Sterility1994;61:248‐51. ">Coulam 1995</a>; <a href="./references#CD000112-bbs2-0006" title="GatenbyPA . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:263‐4. GatenbyPA , CameronK , SimesRJ , AdelsteinS , BennettMJ , JansenRPS , et al. Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: results of a controlled trial. American Journal of Reproductive Immunology1993;29:88‐94. ">Gatenby 1993</a>; <a href="./references#CD000112-bbs2-0007" title="German RSA/IVIG Group. Intravenous immunoglobulin for treatment of recurrent miscarriage. British Journal of Obstetrics and Gynaecology1994;101:1072‐7. ">German RSA/IVIG 1994</a>; <a href="./references#CD000112-bbs2-0008" title="HoHN , GillTJ . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:269‐70. HoHN , GillTJ , HsiehHJ , JiangJJ , LeeTY , HsiehCY . Immunotherapy for recurrent spontaneous abortions in a Chinese population. American Journal of Reproductive Immunology1991;25:10‐5. ">Ho 1991</a>; <a href="./references#CD000112-bbs2-0009" title="IlleniMT , MarelliG , ParazziniF , AcaiaB , BoccioloneL , BontempelliM , et al. Immunotherapy and recurrent abortion: a randomized clinical trial. Human Reproduction1994;9:1247‐9. ParazziniF . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:265. ">Illeni 1994</a>; <a href="./references#CD000112-bbs2-0010" title="JablonowskaB , SelbingA , PalfiM , ErnerudhJ , KjellbergS , LindtonB . Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double‐blind placebo‐controlled study. Human Reproduction1999;14:838‐41. ">Jablonowska 1999</a>; <a href="./references#CD000112-bbs2-0011" title="JohnsonPM , RamsdenGH , ChiaKV , HartCA , FarquharsonRG , FrancisWJA . A combined randomised double‐blind and open study of trophoblast membrane infusion (TMI) in unexplained recurrent miscarriage. In: ChaouatG , MowbrayJ editor(s). Cellular Molecular Biology of the Materno‐Fetal Relationship. Vol. 212, Colloque INSERM/John Libbey Eurotext Ltd, 1991:277‐84. ">Johnson 1991</a>; <a href="./references#CD000112-bbs2-0012" title="KilpatrickDC . Department of Transfusion Medicine, The Royal Infirmary, Edinburgh EH3 9HB, Scotland. Personal communication1994. KilpatrickDC , ListonW . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:264. ">Kilpatrick 1994</a>; <a href="./references#CD000112-bbs2-0013" title="MowbrayJF , GibbingsC , LiddellH , ReginaldPW , UnderwoodJL , BeardRW . Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells. Lancet1985;1:941‐3. MowbrayJF , UnderwoodJL . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:261. ">Mowbray 1985</a>; <a href="./references#CD000112-bbs2-0014" title="KarrisonTG , OberC . Recurrent miscarriage (remis) study: how should data from women who do not become pregnant be handled?. Controlled Clinical Trials1998;19:430‐9. OberC , KarrisonT , OdemRB , BarnesRB , BranchDW , StephensonMD . Mononuclear‐cell immunisation in prevention of recurrent miscarriages: a randomised trial. Lancet1999;354:365‐9. ">Ober 1999</a>; <a href="./references#CD000112-bbs2-0015" title="PandeyMK , AgrawalS . Induction of MLR‐Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion. International Immunopharmacology2004;4:289‐98. PandeyMK , ThakurS , AgrawalS . Lymphocyte immunotherapy and its probable mechanism in the maintenance of pregnancy in women with recurrent spontaneous abortion. Archives of Gynecology and Obstetrics2004;269:161‐72. ">Pandey 2004</a>; <a href="./references#CD000112-bbs2-0016" title="PerinoA , VassiliadisA , VucetichaR , ColacurciN , MenatoG , CignittiM , et al. Short‐term therapy for recurrent abortion using intravenous immunoglobulins: results of a double‐blind placebo‐controlled Italian study. Human Reproduction1997;12:2388‐92. ">Perino 1997</a>; <a href="./references#CD000112-bbs2-0017" title="ReznikoffMF . INTS [Laboratoire], 6 rue Cabanel, 75015 Paris, France. Personal communication1994. Reznikoff‐EtievantMF . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:266‐7. ">Reznikoff 1994</a>; <a href="./references#CD000112-bbs2-0018" title="ScottJR , BranchWD , DudleyD . Department of Obstetrics and Gynecology, University of Utah Medical Center, Salt Lake City, Utah 84132, USA. Personal communication1994. ScottJR , BranchWD , DudleyDJ , HatasakaHH . Immunotherapy for recurrent pregnancy loss: the University of Utah perspective. In: DonderoF , JohnsonP editor(s). Reproductive Immunology. Serono Symposium Publications, Raven Press, 1997:255‐7. ">Scott 1994</a>; <a href="./references#CD000112-bbs2-0019" title="StephensonMD , DreherK , HoulihanE , WuV . Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double blinded, placebo controlled trial. American Journal of Reproductive Immunology1998;39:82‐8. ">Stephenson 1998</a>; <a href="./references#CD000112-bbs2-0020" title="Stray‐PedersonS . Department of Obstetrics and Gynecology, University of Oslo, Oslo, 1 Norway. Personal communication1994. ">Stray‐Pederson 1994</a>). In order to include the highest number of studies possible, this was expanded to include pregnancies alive after 20 weeks of gestation (<a href="./references#CD000112-bbs2-0001" title="CauchiMN . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:263. CauchiMN , LimD , YoungDE , KlossM , PepperellRJ . Treatment of recurrent aborters by immunization with paternal cells ‐ controlled trial. American Journal of Reproductive Immunology1991;25:16‐7. ">Cauchi 1991</a>; <a href="./references#CD000112-bbs2-0019" title="StephensonMD , DreherK , HoulihanE , WuV . Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double blinded, placebo controlled trial. American Journal of Reproductive Immunology1998;39:82‐8. ">Stephenson 1998</a>). </p> </section> </section> <section id="CD000112-sec-0082"> <h4 class="title">Excluded studies</h4> <p>See <a href="./references#CD000112-bbs1-0002" title="">Excluded studies</a>. </p> <p>In total, 19 studies were excluded. Eight studies were outside the scope of our review (<a href="./references#CD000112-bbs2-0022" title="CheckJH , TarquiniP , GandyP , LauerC . A randomized study comparing the efficacy of reducing the spontaneous abortion rate following lymphocyte immunotherapy and progesterone treatment vs progesterone alone in primary habitual aborters. Gynecologic and Obstetric Investigation1995;39:257‐61. ">Check 1995</a>; <a href="./references#CD000112-bbs2-0024" title="CowchockFS , SmithJB . Fertility among women with recurrent spontaneous abortions ‐ the effect of paternal cell immunization treatment. American Journal of Reproductive Immunology1995;33:176‐81. ">Cowchock 1995</a>; <a href="./references#CD000112-bbs2-0030" title="QuenbyS . A randomised controlled trial of prednisolone for women with recurrent miscarriage and high levels of uterine natural killer cells in the endometrium. Current Controlled Trials (www.controlled‐trials.com/) (accessed 30 October 2007). ">Quenby 2007</a>; <a href="./references#CD000112-bbs2-0033" title="ScarpelliniF , SbraciaM . Use of granulocyte colony‐stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Human Reproduction2009;24(11):2703‐8. [PUBMED: 19617208] ">Scarpellini 2009</a>; <a href="./references#CD000112-bbs2-0034" title="ScarpelliniF , SbraciaM . Granulocyte colony‐stimulating factor for the treatment of recurrent miscarriage. Journal of Reproductive Immunology2011;90(2):158‐9. ">Scarpellini 2011</a>; <a href="./references#CD000112-bbs2-0037" title="TangAW , AlfirevicZ , TurnerMA , DruryJ , QuenbyS . Prednisolone Trial: Study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uNK) cells in the endometrium. Trials2009;10:102. ">Tang 2009</a>; <a href="./references#CD000112-bbs2-0038" title="TangAW , AlfirevicZ , TurnerMA , DruryJ , ToppingJ , DawoodF , et al. A pilot, double blind randomised controlled trial of prednisolone for women with recurrent miscarriage and raised uterine natural killer cell density. Human Reproduction2011;26(Suppl 1):i48‐9. ">Tang 2011</a>; <a href="./references#CD000112-bbs2-0039" title="TangAW , AlfirevicZ , TurnerMA , DruryJA , SmallR , QuenbyS . A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant. Human Reproduction2013;28(7):1743‐52. ">Tang 2013</a>). Three studies included participants that do not meet our inclusion criteria: <a href="./references#CD000112-bbs2-0023" title="ChristiansenOB , ChristiansenBS , HusthM , MathiesenO , LauritsenJ , GrunnetN . Prospective study of anticardiolipin antibodies in immunized and untreated women with recurrent spontaneous abortions. Fertility and Sterility1992;58:328‐34. ">Christiansen 1992</a> included patients who had anticardiolipin antibodies, <a href="./references#CD000112-bbs2-0029" title="MahmoudF , DiejomaohM , OmuA , AbulH , HainesD . Effect of IgG therapy on lymphocyte subpopulations in the peripheral blood of Kuwaiti women experiencing recurrent pregnancy loss. Gynecologic and Obstetric Investigation2004;58(2):77‐83. ">Mahmoud 2004</a> included women who were antiphospholipid syndrome positive, and <a href="./references#CD000112-bbs2-0036" title="StephensonMD , KuttehWH , PurkissS , LibrachC , SchultzP , HoulihanE , et al. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo‐controlled trial. Human Reproduction2010;25(9):2203‐9. ">Stephenson 2010</a> included women with at least one ongoing gestation beyond 20 weeks without clarifying the number of prior live births. Three studies (<a href="./references#CD000112-bbs2-0021" title="AokiK . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:268. AokiK , KajiuraS , MatsumotoY , YagamiY . Clinical evaluation of immunotherapy in early pregnancy with x‐irradiated paternal mononuclear cells for primary recurrent aborters. American Journal of Obstetrics and Gynecology1993;169:649‐53. ">Aoki 1993</a>; <a href="./references#CD000112-bbs2-0026" title="KimCH , LeeKH , KimSH , ChaeHD , KangBM , JungKS . Effect of etanercept treatment in women with unexplained primary recurrent pregnancy loss. Human Reproduction2012;27(Suppl 2):P098. ">Kim 2012</a>; <a href="./references#CD000112-bbs2-0028" title="LiD , LiC , ZhuY . Comparative study of the third party and paternal leukocyte immunization in recurrent spontaneous abortion of lowered maternal‐fetal immuno‐recognition. Chinese Journal of Obstetrics and Gynecology1998;33:597‐600. ">Li 1998</a>) did not have a placebo and instead randomized to two different treatments. Two studies (<a href="./references#CD000112-bbs2-0031" title="RedmanCWG . UK multicenter paternal cell immunization trial. Nuffeld Department of Obstetrics and Gynecology Maternity Department, John Radcliffe Hospital, Headington, Oxford OX3 9DU. Personal communication1996. ">Redman 1996</a>; <a href="./references#CD000112-bbs2-0035" title="StephensonM , HoulihanE , DayaS , ClamanP , GravesG , KuttehW . Intravenous immunoglobulin (IVIG) for treatment of unexplained secondary recurrent miscarriage: a prospective, randomized, double blinded, placebo‐controlled trial. Frontiers in Fetal Health2001;3(4):105‐6. ">Stephenson 2001</a>) did not report any data and two other studies (<a href="./references#CD000112-bbs2-0025" title="KilpatrickDC , KitchinAJ , ListonWA . Humoral immune response to lymphocyte antigens in early pregnancy and after leucocyte immunotherapy. Journal of Obstetrics and Gynaecology1993;13:77‐81. ">Kilpatrick 1993</a>; <a href="./references#CD000112-bbs2-0027" title="KwonSK , KimCH , AhnJW , LeeKH , ChaeHD , KangBM . Effect of intravenous immunoglobulin on pregnancy outcome following IVF/ICSI in infertile patients with endometriosis. Fertility and Sterility2012;98 Suppl 1(3):S263 Abstract no:O‐511. ">Kwon 2012</a>) did not report our outcome of interest (live birth). One study was not a randomized controlled trial (<a href="./references#CD000112-bbs2-0032" title="SagotP , BignonJD , CesbronA , LaurentFX , AdjouC , MullerJY . Immunological treatment of spontaneous repeated abortions. The value of transfusing the partner's leukocytes in the third week of gestation. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1993;22:471‐5. ">Sagot 1993</a>). </p> </section> </section> <section id="CD000112-sec-0083"> <h3 class="title">Risk of bias in included studies</h3> <p>Overall risk of bias for the majority of included studies was judged to be low. Assessment of the methodological quality of the included studies was based on the following 'Risk of bias' domains: selection bias (method of randomization and allocation concealment), performance bias, detection bias, attrition bias (loss of participants from the analyses) and reporting bias. A summary of 'Risk of bias' assessments for each study, and for included trials overall, are set out in <a href="#CD000112-fig-0001">Figure 1</a> and <a href="#CD000112-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD000112-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD000112-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_n/nCD000112-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD000112-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD000112-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_n/nCD000112-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD000112-sec-0084"> <h4 class="title">Allocation</h4> <p>In the majority of included studies selection bias was assessed as being low with adequate methods of both sequence generation and allocation concealment. Only three trials provided insufficient information to permit evaluation of selection bias. </p> </section> <section id="CD000112-sec-0085"> <h4 class="title">Blinding</h4> <p>Performance bias was minimized because all studies with co‐interventions were excluded, and the majority of included trials provided adequate documentation of blinding of both provider and participant. One trial did not provide sufficient information to permit evaluation of performance and detection bias (<a href="./references#CD000112-bbs2-0008" title="HoHN , GillTJ . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:269‐70. HoHN , GillTJ , HsiehHJ , JiangJJ , LeeTY , HsiehCY . Immunotherapy for recurrent spontaneous abortions in a Chinese population. American Journal of Reproductive Immunology1991;25:10‐5. ">Ho 1991</a>). Another trial (<a href="./references#CD000112-bbs2-0009" title="IlleniMT , MarelliG , ParazziniF , AcaiaB , BoccioloneL , BontempelliM , et al. Immunotherapy and recurrent abortion: a randomized clinical trial. Human Reproduction1994;9:1247‐9. ParazziniF . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:265. ">Illeni 1994</a>) did not blind the treatment or control groups to patients, physicians, or investigators. </p> </section> <section id="CD000112-sec-0086"> <h4 class="title">Incomplete outcome data</h4> <p>Attrition bias was limited because included studies accounted for participants who withdrew from the trial. Only one study (<a href="./references#CD000112-bbs2-0008" title="HoHN , GillTJ . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:269‐70. HoHN , GillTJ , HsiehHJ , JiangJJ , LeeTY , HsiehCY . Immunotherapy for recurrent spontaneous abortions in a Chinese population. American Journal of Reproductive Immunology1991;25:10‐5. ">Ho 1991</a>) had an attrition of approximately 20%. Four other studies had missing data, but these were either similar for both treatment and control groups and/or were a small portion and not likely to have a relevant impact on the effect estimates. </p> </section> <section id="CD000112-sec-0087"> <h4 class="title">Selective reporting</h4> <p>Reporting bias was minimal since inclusion of a study for this review requires that the outcome be reported in a pre‐specified manner. </p> </section> <section id="CD000112-sec-0088"> <h4 class="title">Other potential sources of bias</h4> <p>The majority of studies included were free of other sources of bias.</p> </section> </section> <section id="CD000112-sec-0089"> <h3 class="title" id="CD000112-sec-0089">Effects of interventions</h3> <p>Twenty randomized controlled trials of high quality were included involving total of 1137 women. </p> <section id="CD000112-sec-0090"> <h4 class="title">Paternal white cell immunization versus placebo</h4> <p>Twelve randomized controlled trials comparing paternal white cell immunization versus placebo involving a total of 641 women were included. </p> <section id="CD000112-sec-0091"> <h5 class="title">Primary outcomes</h5> <p>Women who were treated with paternal cell immunization were not at increased odds for live birth as compared to placebo, Peto odds ratio (OR) 1.23, 95% confidence interval (CI) 0.89 to 1.70 (<a href="./references#CD000112-fig-0003" title="">Analysis 1.1</a>). The use of intention‐to‐treat analysis did not result in significant differences between paternal cell immunization treatment and control groups in terms of subsequent live births (four trials, 350 women) OR 1.38, 95% CI 0.90 to 2.12 (<a href="./references#CD000112-fig-0004" title="">Analysis 1.2</a>). </p> <p>We investigated for reporting biases using a funnel plot which appeared symmetric on visual assessment. Thus no further exploratory analyses to investigate reporting biases were pursued. </p> </section> <section id="CD000112-sec-0092"> <h5 class="title">Secondary outcomes</h5> <p>Not within the scope of this review.</p> </section> </section> <section id="CD000112-sec-0093"> <h4 class="title">Donor white cell immunization versus placebo</h4> <p>Third‐party donor white cell immunization (three trials, 156 women) did not result in increased odds for live birth as compared to placebo, Peto OR 1.39, 95% CI 0.68 to 2.82 (<a href="./references#CD000112-fig-0005" title="">Analysis 2.1</a>). </p> </section> <section id="CD000112-sec-0094"> <h4 class="title">Trophoblast membrane immunization versus placebo</h4> <p>Trophoblast membrane infusion (one trial, 37 women) did not result in increased odds of live birth as compared to placebo, Peto OR 0.40, 95% CI 0.11 to 1.45 (<a href="./references#CD000112-fig-0006" title="">Analysis 3.1</a>). </p> </section> <section id="CD000112-sec-0095"> <h4 class="title">Intravenous immunoglobulin versus placebo</h4> <p>Intravenous immunoglobulin (IVIG) (eight trials, 303 women) did not result in increased odds of live birth as compared to placebo, Peto OR 0.98, 95% CI 0.61 to 1.58 (<a href="./references#CD000112-fig-0007" title="">Analysis 4.1</a>). The earlier published trials tended to give higher estimates of treatment effect, although these were not statistically significant. Thus the possibility of publication bias is low. The use of intention‐to‐treat analysis did not result in significant differences between IVIG treatment and control groups in terms of subsequent live births: IVIG (four trials, 279 women), OR 1.18, 95% CI 0.72 to 1.93 (<a href="./references#CD000112-fig-0007" title="">Analysis 4.1</a>). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD000112-sec-0096" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD000112-sec-0096"></div> <section id="CD000112-sec-0097"> <h3 class="title" id="CD000112-sec-0097">Summary of main results</h3> <p>In this updated version of the review, we assessed a total of 15 studies (seven new studies identified from an updated search; and eight studies that were awaiting assessment at the time of the last review). Fourteen of these studies were excluded as they did not meet inclusion criteria for our review and one of these studies is awaiting translation into the English language to allow classification. In total, 20 randomized controlled trials of high quality were included involving a total of 1137 women. The results of this review indicate no improvement in live births with paternal cell immunization, third‐party donor cell immunization, trophoblast membrane immunization, or intravenous immunoglobulin (IVIG) immunotherapy regimens. </p> </section> <section id="CD000112-sec-0098"> <h3 class="title" id="CD000112-sec-0098">Overall completeness and applicability of evidence</h3> <p>There is considerable variation in reported subsequent live birth among studies examining immunotherapy for recurrent miscarriage. This may be attributed to significant variation in the participants included, methodology, intervention, and treatment regimen. Given the considerable costs for immunotherapy and potential for serious side effects (<a href="./references#CD000112-bbs2-0043" title="ClarkDA , DayaS . Trials and tribulations in the treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1991;25:18‐24. ">Clark 1991</a>; <a href="./references#CD000112-bbs2-0049" title="CoulamCB , ClarkDA , CollinsJ , ScottJR . Worldwide collaborative observational study and meta‐analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:55‐72. ">Coulam 1994</a>; <a href="./references#CD000112-bbs2-0052" title="DuhemC , DicatoMA , RiesF . Side‐effects of intravenous immunoglobulins. Clinical and Experimental Immunology1994;97:79‐83. ">Duhem 1994</a>), it is important to establish the efficacy of immunotherapy for the treatment of recurrent miscarriage. While we performed individual analysis for paternal cell immunization, third‐party donor cell immunization, trophoblast membrane immunization, and IVIG, our ability to reach conclusive findings is limited by heterogeneity in dose, duration, and timing of immunotherapy. Subgroup analysis by these variables was not feasible due to the small number of included trials and participants. However, our review was inclusive of published and unpublished data as well as English and non‐English data. Furthermore, our review was restricted to randomized controlled trials of moderate to high quality, increasing the level of confidence in our conclusion that immunotherapy does not improve the live birth rate in women with unexplained recurrent miscarriage. Moreover, women should be spared the pain and grief associated with false expectations that an ineffective treatment might work. These therapies should no longer be offered as treatment for unexplained recurrent pregnancy loss. </p> </section> <section id="CD000112-sec-0099"> <h3 class="title" id="CD000112-sec-0099">Quality of the evidence</h3> <p>The overall quality of the trials included in this review was moderate to high since only randomized controlled trials were included and all but one trial (<a href="./references#CD000112-bbs2-0009" title="IlleniMT , MarelliG , ParazziniF , AcaiaB , BoccioloneL , BontempelliM , et al. Immunotherapy and recurrent abortion: a randomized clinical trial. Human Reproduction1994;9:1247‐9. ParazziniF . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:265. ">Illeni 1994</a>) was double‐blinded. The overall risk for bias of the included trials is low. None of the studies assessed were at high risk of bias for the majority of the domains. Only two trials were noted to be at high risk for bias in one or two areas. <a href="./references#CD000112-bbs2-0008" title="HoHN , GillTJ . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:269‐70. HoHN , GillTJ , HsiehHJ , JiangJJ , LeeTY , HsiehCY . Immunotherapy for recurrent spontaneous abortions in a Chinese population. American Journal of Reproductive Immunology1991;25:10‐5. ">Ho 1991</a> was noted to be at high risk for attrition bias, with outcomes not reported in approximately 20% of the participants due to early reporting for reasons unstated. <a href="./references#CD000112-bbs2-0009" title="IlleniMT , MarelliG , ParazziniF , AcaiaB , BoccioloneL , BontempelliM , et al. Immunotherapy and recurrent abortion: a randomized clinical trial. Human Reproduction1994;9:1247‐9. ParazziniF . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:265. ">Illeni 1994</a> was found to be at high risk for performance and detection bias because the treatment and control groups were not blinded to investigators, patients, or physicians. There were also several trials that did not provide clear information on methodology. Three trials (<a href="./references#CD000112-bbs2-0002" title="ChristiansenOB , ChristiansenBS , HusthM , MathiesenO , LauritsenJ , GrunnetN . Prospective study of anticardiolipin antibodies in immunized and untreated women with recurrent spontaneous abortions. Fertility and Sterility1992;58:328‐34. ChristiansenOB , MathiesenO , HusthM , LauritsenJG , GrunnetJ . Placebo‐controlled trial of active immunization with third party leukocytes in recurrent miscarriage. Acta Obstetricia et Gynecologica Scandinavica1994;3:261‐8. ">Christiansen 1994</a>; <a href="./references#CD000112-bbs2-0008" title="HoHN , GillTJ . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:269‐70. HoHN , GillTJ , HsiehHJ , JiangJJ , LeeTY , HsiehCY . Immunotherapy for recurrent spontaneous abortions in a Chinese population. American Journal of Reproductive Immunology1991;25:10‐5. ">Ho 1991</a>; <a href="./references#CD000112-bbs2-0013" title="MowbrayJF , GibbingsC , LiddellH , ReginaldPW , UnderwoodJL , BeardRW . Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells. Lancet1985;1:941‐3. MowbrayJF , UnderwoodJL . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:261. ">Mowbray 1985</a>) were reported as randomized trials, but did not provide sufficient information to permit evaluation of their random sequence generation. The risk of selection bias was unclear for three trials (<a href="./references#CD000112-bbs2-0008" title="HoHN , GillTJ . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:269‐70. HoHN , GillTJ , HsiehHJ , JiangJJ , LeeTY , HsiehCY . Immunotherapy for recurrent spontaneous abortions in a Chinese population. American Journal of Reproductive Immunology1991;25:10‐5. ">Ho 1991</a>; <a href="./references#CD000112-bbs2-0013" title="MowbrayJF , GibbingsC , LiddellH , ReginaldPW , UnderwoodJL , BeardRW . Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells. Lancet1985;1:941‐3. MowbrayJF , UnderwoodJL . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:261. ">Mowbray 1985</a>; <a href="./references#CD000112-bbs2-0015" title="PandeyMK , AgrawalS . Induction of MLR‐Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion. International Immunopharmacology2004;4:289‐98. PandeyMK , ThakurS , AgrawalS . Lymphocyte immunotherapy and its probable mechanism in the maintenance of pregnancy in women with recurrent spontaneous abortion. Archives of Gynecology and Obstetrics2004;269:161‐72. ">Pandey 2004</a>) because their methods for allocation concealment were not described. One trial (<a href="./references#CD000112-bbs2-0008" title="HoHN , GillTJ . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:269‐70. HoHN , GillTJ , HsiehHJ , JiangJJ , LeeTY , HsiehCY . Immunotherapy for recurrent spontaneous abortions in a Chinese population. American Journal of Reproductive Immunology1991;25:10‐5. ">Ho 1991</a>), did not provide sufficient information to permit evaluation of performance and detection bias. Four studies (<a href="./references#CD000112-bbs2-0001" title="CauchiMN . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:263. CauchiMN , LimD , YoungDE , KlossM , PepperellRJ . Treatment of recurrent aborters by immunization with paternal cells ‐ controlled trial. American Journal of Reproductive Immunology1991;25:16‐7. ">Cauchi 1991</a>; <a href="./references#CD000112-bbs2-0006" title="GatenbyPA . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:263‐4. GatenbyPA , CameronK , SimesRJ , AdelsteinS , BennettMJ , JansenRPS , et al. Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: results of a controlled trial. American Journal of Reproductive Immunology1993;29:88‐94. ">Gatenby 1993</a>; <a href="./references#CD000112-bbs2-0013" title="MowbrayJF , GibbingsC , LiddellH , ReginaldPW , UnderwoodJL , BeardRW . Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells. Lancet1985;1:941‐3. MowbrayJF , UnderwoodJL . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:261. ">Mowbray 1985</a>; <a href="./references#CD000112-bbs2-0017" title="ReznikoffMF . INTS [Laboratoire], 6 rue Cabanel, 75015 Paris, France. Personal communication1994. Reznikoff‐EtievantMF . Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:266‐7. ">Reznikoff 1994</a>) reported missing data, although the risk for attrition bias is likely low given the similarly small proportion of missing data in treatment and control groups. </p> <p>The use of so‐called intention‐to‐treat analysis has been suggested as the best method of comparing the effects of any treatment on a given disease process versus those of placebo, because it more closely resembles actual patient care in everyday clinical practice. The validity of intention‐to‐treat studies evaluating the effects of preconceptional treatment on pregnancy outcome has been questioned since women who do not achieve pregnancy cannot have a primary outcome. Most studies of immunotherapy for recurrent miscarriage given prior to conception excluded women from analysis if pregnancy was not achieved. However, two recent studies of paternal cell immunization (<a href="./references#CD000112-bbs2-0014" title="KarrisonTG , OberC . Recurrent miscarriage (remis) study: how should data from women who do not become pregnant be handled?. Controlled Clinical Trials1998;19:430‐9. OberC , KarrisonT , OdemRB , BarnesRB , BranchDW , StephensonMD . Mononuclear‐cell immunisation in prevention of recurrent miscarriages: a randomised trial. Lancet1999;354:365‐9. ">Ober 1999</a>; <a href="./references#CD000112-bbs2-0015" title="PandeyMK , AgrawalS . Induction of MLR‐Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion. International Immunopharmacology2004;4:289‐98. PandeyMK , ThakurS , AgrawalS . Lymphocyte immunotherapy and its probable mechanism in the maintenance of pregnancy in women with recurrent spontaneous abortion. Archives of Gynecology and Obstetrics2004;269:161‐72. ">Pandey 2004</a>) included outcome data from all treated women, regardless of whether or not conception occurred. In the present review, it was also possible to combine the results of four trials of each type of immunotherapy using an intention‐to‐treat analysis. No significant benefit was found. </p> </section> <section id="CD000112-sec-0100"> <h3 class="title" id="CD000112-sec-0100">Potential biases in the review process</h3> <p>We took steps to minimize introduction of bias at every stage of the review process. We were able to identify all relevant trials, including unpublished studies and published abstracts from conference proceedings, and those from English and non‐English publications alike. At least two review authors independently assessed each trial, performed data extraction, and assessed quality for each of the included trials. A member of the review team was an author on one of the included trials (<a href="./references#CD000112-bbs2-0018" title="ScottJR , BranchWD , DudleyD . Department of Obstetrics and Gynecology, University of Utah Medical Center, Salt Lake City, Utah 84132, USA. Personal communication1994. ScottJR , BranchWD , DudleyDJ , HatasakaHH . Immunotherapy for recurrent pregnancy loss: the University of Utah perspective. In: DonderoF , JohnsonP editor(s). Reproductive Immunology. Serono Symposium Publications, Raven Press, 1997:255‐7. ">Scott 1994</a>) but was not involved in assessing the quality and risk of bias for this trial or carrying out data extraction of this trial. No new unpublished trials have been identified since the initial review. Previously identified unpublished trials have remained unpublished and our assessment of their methodology and potential biases are limited to the records of the initial communication between our authors and the authors of the unpublished trials. </p> </section> <section id="CD000112-sec-0101"> <h3 class="title" id="CD000112-sec-0101">Agreements and disagreements with other studies or reviews</h3> <p>Conclusions about the value of paternal cell immunization in recurrent miscarriage have been conflicting and highly dependent on the methods used for meta‐analysis. The earliest meta‐analysis, which included only published trials, reported no improvement in live birth rates among women with recurrent miscarriage (<a href="./references#CD000112-bbs2-0053" title="FraserEJ , GrimesDA , SchultzKF . Immunization as therapy for recurrent spontaneous abortion: a review and meta‐analysis. Obstetrics &amp; Gynecology1993;82:854‐9. ">Fraser 1993</a>). Using a different data set and adjusting for maternal age and the number of prior miscarriages, paternal cell immunization appeared to slightly increase the live birth rate over placebo (<a href="./references#CD000112-bbs2-0018" title="ScottJR , BranchWD , DudleyD . Department of Obstetrics and Gynecology, University of Utah Medical Center, Salt Lake City, Utah 84132, USA. Personal communication1994. ScottJR , BranchWD , DudleyDJ , HatasakaHH . Immunotherapy for recurrent pregnancy loss: the University of Utah perspective. In: DonderoF , JohnsonP editor(s). Reproductive Immunology. Serono Symposium Publications, Raven Press, 1997:255‐7. ">Scott 1994</a>). Another meta‐analysis performed simultaneously using similar methodology also demonstrated a small but significant benefit (<a href="./references#CD000112-bbs2-0045" title="CollinsJ , RobertsR . Immunotherapy for recurrent spontaneous abortion: analysis 1. American Journal of Reproductive Immunology1994;32:275‐80. ">Collins 1994</a>; <a href="./references#CD000112-bbs2-0049" title="CoulamCB , ClarkDA , CollinsJ , ScottJR . Worldwide collaborative observational study and meta‐analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:55‐72. ">Coulam 1994</a>). This benefit disappeared when the largest published trial was included (<a href="./references#CD000112-bbs2-0014" title="KarrisonTG , OberC . Recurrent miscarriage (remis) study: how should data from women who do not become pregnant be handled?. Controlled Clinical Trials1998;19:430‐9. OberC , KarrisonT , OdemRB , BarnesRB , BranchDW , StephensonMD . Mononuclear‐cell immunisation in prevention of recurrent miscarriages: a randomised trial. Lancet1999;354:365‐9. ">Ober 1999</a>). Even so, the most recent randomized controlled trial of paternal cell immunization trials reported a significant increase in live births among treated women (<a href="./references#CD000112-bbs2-0015" title="PandeyMK , AgrawalS . Induction of MLR‐Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion. International Immunopharmacology2004;4:289‐98. PandeyMK , ThakurS , AgrawalS . Lymphocyte immunotherapy and its probable mechanism in the maintenance of pregnancy in women with recurrent spontaneous abortion. Archives of Gynecology and Obstetrics2004;269:161‐72. ">Pandey 2004</a>). </p> <p>In the current review, we were unable to identify a statistically significant improvement in live birth when paternal cell immunization was used to treat women with recurrent miscarriage. Our findings disagree from those of the most recent meta‐analysis (for several reasons. Pandy et al. introduced bias by including control patients who received neither treatment nor placebo. They pooled study group pregnancy outcomes and control group (when available) outcomes in lieu of using the more statistically appropriate method of weighted averages in either a fixed‐effect or random‐effects model. The inclusion of non‐randomized trials in a meta‐analysis of randomized trials is likely to bias the results in favor of a significant difference. </p> <p>Paternal cell immunization using viable mononuclear cells carries a risk for transmission of hepatitis and human immunodeficiency virus (HIV). Reactions are uncommon but include soreness and redness at the injection site, fever, maternal platelet alloimmunization, blood group sensitization, and cutaneous graft‐versus‐host‐like reaction (<a href="./references#CD000112-bbs2-0043" title="ClarkDA , DayaS . Trials and tribulations in the treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology1991;25:18‐24. ">Clark 1991</a>; <a href="./references#CD000112-bbs2-0049" title="CoulamCB , ClarkDA , CollinsJ , ScottJR . Worldwide collaborative observational study and meta‐analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. American Journal of Reproductive Immunology1994;32:55‐72. ">Coulam 1994</a>). Rare adverse pregnancy outcomes have also been reported, including placental abruption, placenta accreta, oligohydramnios, pre‐eclampsia, fetal growth retardation, preterm delivery, renal anomalies, trisomy 21 and 13, and an unusual case of undefined immunodeficiency disease. One trial (<a href="./references#CD000112-bbs2-0014" title="KarrisonTG , OberC . Recurrent miscarriage (remis) study: how should data from women who do not become pregnant be handled?. Controlled Clinical Trials1998;19:430‐9. OberC , KarrisonT , OdemRB , BarnesRB , BranchDW , StephensonMD . Mononuclear‐cell immunisation in prevention of recurrent miscarriages: a randomised trial. Lancet1999;354:365‐9. ">Ober 1999</a>) indicated that women who have received lymphocyte immunotherapy may have a higher incidence of subsequent miscarriage than women who did not receive such cellular products. The Director of the Office of Therapeutics Research and Review, United States Food and Drug Administration (FDA), sent a letter on January 30, 2002 to physicians believed to be using lymphocyte immunotherapy to prevent miscarriages. He informed them that the injectable products used in lymphocyte immunotherapy do not have the required FDA approval and are considered investigational drugs that pose several safety concerns. Administration of such cells or cellular products in humans can only be performed in the United States as part of clinical investigations, and then only if there is an Investigational New Drug application (IND) in effect. All institutions, reproductive centers, and physicians were reminded that they should not administer allogeneic cells or cellular products to miscarriage patients until an IND has been submitted and reviewed by the FDA's Center for Biologics Evaluation and Research. </p> <p>Intravenous immunoglobulin has become a popular treatment for unexplained recurrent miscarriage in some centers. One meta‐analysis of four randomized trials reported a treatment effect of 10% (<a href="./references#CD000112-bbs2-0050" title="DayaS , GunbyJ , ClarkDA . Intravenous immunoglobulin therapy for recurrent spontaneous abortion: a meta‐analysis. American Journal of Reproductive Immunology1998;39:69‐76. ">Daya 1998</a>). However, a more recent meta‐analysis using both published data (MAL) and review of individual patient data (MAP) from six trials indicates that IVIG treatment has no clinically meaningful effect on the live birth rate (<a href="./references#CD000112-bbs2-0051" title="DayaS , GunbyJ , PorterF , ScottJ , ClarkDA . Critical analysis of intravenous immunoglobulin therapy for recurrent miscarriage. Human Reproduction Update1999;5(5):475‐82. ">Daya 1999</a>). The authors of the latest randomized trial (<a href="./references#CD000112-bbs2-0004" title="ChristiansenOB , PedersenB , RosgaardA , Husth . A randomized, double‐blind, placebo‐controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage. Human Reproduction2002;17(3):809‐16. ">Christiansen 2002</a>) suggested that IVIG may have a role in the treatment of women with secondary recurrent miscarriage. However, inclusion of their data with the six other trials shows no significant increase in the overall pregnancy success rate over placebo or no treatment. These data on the use of IVIG for recurrent miscarriage are important because of its expense, not to mention the serious and life‐threatening reactions to IVIG, which have occasionally been reported (<a href="./references#CD000112-bbs2-0052" title="DuhemC , DicatoMA , RiesF . Side‐effects of intravenous immunoglobulins. Clinical and Experimental Immunology1994;97:79‐83. ">Duhem 1994</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD000112-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/urn:x-wiley:14651858:media:CD000112:CD000112-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_t/tCD000112-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD000112-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_n/nCD000112-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/full#CD000112-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_n/nCD000112-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000112-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/urn:x-wiley:14651858:media:CD000112:CD000112-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_t/tCD000112-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD000112-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_n/nCD000112-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/full#CD000112-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_n/nCD000112-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000112-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/urn:x-wiley:14651858:media:CD000112:CD000112-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_t/tCD000112-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Paternal white cell immunization versus placebo, Outcome 1 Live birth rate." data-id="CD000112-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_n/nCD000112-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Paternal white cell immunization versus placebo, Outcome 1 Live birth rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/references#CD000112-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_n/nCD000112-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000112-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/urn:x-wiley:14651858:media:CD000112:CD000112-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_t/tCD000112-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Paternal white cell immunization versus placebo, Outcome 2 Live birth rate ‐ intention‐to‐treat." data-id="CD000112-fig-0004" src="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_n/nCD000112-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Paternal white cell immunization versus placebo, Outcome 2 Live birth rate ‐ intention‐to‐treat. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/references#CD000112-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_n/nCD000112-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000112-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/urn:x-wiley:14651858:media:CD000112:CD000112-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_t/tCD000112-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Donor white cell immunization versus placebo, Outcome 1 Live birth rate." data-id="CD000112-fig-0005" src="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_n/nCD000112-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Donor white cell immunization versus placebo, Outcome 1 Live birth rate.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/references#CD000112-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_n/nCD000112-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000112-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/urn:x-wiley:14651858:media:CD000112:CD000112-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_t/tCD000112-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Trophoblast membrane immunization versus placebo, Outcome 1 Live birth rate." data-id="CD000112-fig-0006" src="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_n/nCD000112-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Trophoblast membrane immunization versus placebo, Outcome 1 Live birth rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/references#CD000112-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_n/nCD000112-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000112-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/urn:x-wiley:14651858:media:CD000112:CD000112-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_t/tCD000112-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Intravenous immunoglobulin versus placebo, Outcome 1 Live birth rate." data-id="CD000112-fig-0007" src="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_n/nCD000112-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Intravenous immunoglobulin versus placebo, Outcome 1 Live birth rate.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/references#CD000112-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_n/nCD000112-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000112-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/urn:x-wiley:14651858:media:CD000112:CD000112-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_t/tCD000112-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Intravenous immunoglobulin versus placebo, Outcome 2 Live birth rate ‐ intention‐to‐treat." data-id="CD000112-fig-0008" src="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_n/nCD000112-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Intravenous immunoglobulin versus placebo, Outcome 2 Live birth rate ‐ intention‐to‐treat. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/references#CD000112-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/media/CDSR/CD000112/image_n/nCD000112-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="comparison" data-id="CD000112-tbl-0001"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Paternal white cell immunization versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Live birth rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>641</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.89, 1.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Live birth rate ‐ intention‐to‐treat <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [0.90, 2.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Paternal white cell immunization versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/references#CD000112-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000112-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Donor white cell immunization versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Live birth rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.68, 2.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Donor white cell immunization versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/references#CD000112-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000112-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Trophoblast membrane immunization versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Live birth rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.11, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Trophoblast membrane immunization versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/references#CD000112-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000112-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Intravenous immunoglobulin versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Live birth rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>303</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.61, 1.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Live birth rate ‐ intention‐to‐treat <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.72, 1.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Intravenous immunoglobulin versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000112.pub3/references#CD000112-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD000112.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD000112-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD000112-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD000112-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="ru#CD000112-note-0001">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000112\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000112\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000112\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000112\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000112\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000112\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000112\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000112\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000112\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000112\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000112\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000112\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000112\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000112\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000112\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000112\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000112\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000112\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Xx9QLps0&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000112.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000112.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD000112.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD000112.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000112.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740715476694"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000112.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740715476698"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000112.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d880b69cd9374',t:'MTc0MDcxNTQ3Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 